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1. INTRODUCTION 
 Plants, which have one or more of its parts having substances that can be used for 
treatment of diseases, are called medicinal plants. Medicines derived from plants are widely 
famous due to their safety, easy availability and low cost. Herbal medicines may include 
whole parts of plant or mostly prepared from leaves, roots, bark, seed and flowers of plants. 
They are administered orally, inhaled or directly applied in the skin. Medicinal herbs are 
more significant to the health of individual and community .The medicinal value of these 
plants lies in bioactive phytochemical constituents that produce definite physiological action 
on the human body. Some of the most important bioactive phytochemical constituents are 
alkaloids, essential oils, flavonoids, tannins, terpenoids, saponins, phenolic compounds and 
many more. These natural compounds formed the foundations of modern prescription drugs 
as we know today
.
 Use of plants based drugs for curing various ailments is as old as human 
civilization and is used in all cultures throughout history. The primitive man started to 
distinguish between useful and harmful are poisonous plants by trail and errors. A well 
defined herbal pharmacopoeia was developed by tribal people who were based on 
information collected from local flora, religion and culture. The knowledge of medicinal 
plants was gradually developed and passed on from one individual to other, which foundation 
for traditional medicine throughout the world. 
Classification of herbal medicines:    
Herbal medicines are classified into; 
1. Ayurvedic Herbalism  
(Ayurveda meaning science of life) which is derived from Sanskrit word. This system 
originated from Indian medicines about 500 years ago and was practiced in its neighboring 
countries like Srilanka. 
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2. Chinese Herbalism 
3. African Herbalism 
4. Western Herbalism, Greece and Rome were their originating countries which were then 
spread to Europe, North and South America Plants based medicine play an important role in 
world health. Medicinal plants are distributed worldwide but they are very rich in tropical 
countries. Modern medicine from high plants either directly or indirectly derived is estimated 
25%. Herbal medicines might be considered as “diluted drugs”. An adequate amount is 
required by an individual for specified period of time in order to achieve the desire benefits of 
herbal medicines. Every herb is different from other herb; some herbs are safe and effective 
for specified use while other are not. This is not a true preparation that the herbal medicines 
are very safe and free from any side effect because they can produce side effects and can be 
toxic. As each part of plant will have many active constituents and some of its constituents 
may be toxic, however, a high dose is required to cause toxicity because they are not potent. 
Also their adverse effects are relatively infrequent as compared to manufactured drug. 
       Until the nineteenth century, the main source of products used to maintain health were 
medicinal plants when accidentally Friedrich Wohler in 1928 synthesized urea while 
attempting to prepare ammonium cyanate from silver cyanide and ammonium chloride and 
this was the first organic synthesis in history and hence leaded to the era of synthetic 
compounds. With this discovery, the western scientists give their full concentration to the 
newly discovered synthetic lines and ignored a little bit to the phytomedicines but after some 
time they compelled to bounce back to the phytomedicines as they observed that the earlier 
has less side effects as compared to synthetic medicines. However, plants derived medicines 
are far superior to the well defined drugs. For example, the quality and availability of raw 
materials is always a problem, the principles of handling are also unknown and also the 
quality control, i.e. standardization and stability are practically applicable but not too much 
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easy. Herbal medicines are for superior than the synthetic drugs because they are naturally 
occurring, easily available without cost and have minimum side effects. Majority of plants 
have medicinal properties, i.e. most pharmaceutical drugs are originally derived from plants. 
The scientific study of indigenous medicines is called Ethno pharmacology, which is an 
interdisciplinary science practiced all over the world. Standardization herbal preparation is 
termed as phototherapeutic agents or phyto-medicine which contains active constituents, or 
complex mixture of plant materials in the raw or processed form. Phototherapeutic agents are 
usually not recommended to use in emergency treatment because of the fact that they 
normally do not possess an immediate or strong pharmacological action. The modern field of 
phytoscience comprise of the use of medicinal plants and their bioactive phyto-compounds. 
This science is developed from merging of vast range of disciplines that have never been 
linked before combining several different areas of economic, biochemistry, physiology, 
microbiology medicines and agriculture. The development and introduction of new drugs like 
antibiotics, immuno-stimulants and anti tumor agents have led to dramatic success in control 
of many diseases. The drugs derived from plants, however, still from the mainstay of medical 
treatment in the developing countries. According to the June 1983, issue of world Health, it is 
estimated that more than half of the world‟s population relies mainly on traditional remedies. 
Natural products and the medicinal agents derived there from, are also an essential feature in 
the health care system of the remaining of the population residing mainly in developed 
countries, More than 50% of all drugs in clinical use have a natural product origin. Natural 
products continue to play an important role in drug discovery programs of the pharmaceutical 
industry and other research organizations
. 
More than 600 botanical items have been 
recognized in various editions of the United Sates Pharmacopoeia
 
.The fact that most of the 
plant materials have been used over the ages for treatment of diseases is convincing evidence 
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that many of the herbal prescriptions are reasonable safe but scientific toxicological trials are 
still necessary 
[1]
. 
MEDICINAL PLANT:  
Importance and scope  
 Herbs are staging a comeback and herbal „renasissance‟ is happening all over the 
globe. The herbal products today symbolise safety in contrast to the synthetics that are 
regarded as unsafe to human and environment. Although herb had been priced for their 
medicinal, flavouring and aromatic qualities for centuries, the synthetic products of the 
modern age surpassed their importance, for a while. However, the blind dependence on 
synthetic is over and people are returning to the naturals with hope of safety and security. 
 It has been estimated that in developed countries such as United States, plant drugs 
constituents as much as 25% the total drugs. While in fasting developing countries such as 
china and India, the contribution is as much as 80%. Thus, the economic importance of 
medicinal plants is much more to developing countries such as India than to rest of the world. 
These countries provide two third of the plants used in modern system of medicine and the 
health care system of rural population depend on indigenous systems of medicine. Of the 2, 
50, 000 higher plant species on earth, more than 80,000 are medicinal. India is one of the 
world‟s 12 biodiversity centres with the presence of over 45000 different plant species. 
India‟s diversity is unmatched due to the presence of 16 different agro-climate zones, 10 
vegetation zones, 25 biotic provinces and 426 biomes (habitats of specific species). Of these, 
about 15000-20000 plants have good medicinal value. However, only 7000-7500 species are 
used for their medicinal values by traditional communities. This proportion of medicinal 
plants is the highest proportion of plants known for their medicals purpose in any country of 
world for the existing flora of that respective country. The drugs are derived either from the 
whole plant or from different organs, like leaves, stem, bark, flower, seed , etc. Some drugs 
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are prepared from excretory plant product such as gum, resins and latex. Even the allopathic 
system of medicine has adopted a number of plants – derived drugs which form an important 
segment of the modern pharmacopoeia. Some important chemical intermediates needed for 
manufacturing the modern drugs are also obtained from plants (eg. Diosgenin, solasodine, 
beta-ionone). Not only that plant-derived drug offers stable market worldwide , but also plant 
continue to be important source for new drugs.  
 The Indian system of medicine is in the list approved by the National council for 
Alternative Medicine (NCAM), USA, although most of these drugs that claim to cure various 
ailments are yet to be validated scientifically. According to parasnis (2004), the full potentials 
of Ayurveda can be realized only by subjecting the ayurvedic drugs to modern investigation 
techniques. Further acceptance of any clinical trial depends on whether it satisfies modern 
pharmacological and statistical standards or not. Unfortunately, most people practicising 
Ayurveda decline to adopt modern research techniques for evaluation of formulations used in 
the practices. This holds good for other traditional medical practitioners like those of siddha 
and unani medicinal systems too. Scientific validation will not only popularize these 
medicines in India but also render them acceptable, in some form to people in other parts of 
the world. Considering the fact that several disease do not have an ultimate answer in the 
conventional system whether in native regions or throughout the world, an effort to recognize 
the potential of alternative and combinational treatment systems validated through universally 
acceptable methods could provide be very beneficial for the human community at large
[2]
. 
NEUROPHARMACOLOGY 
Introduction: 
 Neuropharmacology is the study of how drugs affect cellular function in the nervous 
system, and the neural mechanisms through which they influence behaviour. There are two 
main branches of neuropharmacology: Behavioral and Molecular. Behavioral 
         INTRODUCTION                                                             
DEPT.OF PHARMACOLOGY, THE ERODE COLLEGE OF PHARMACY & RESEARCH INSTITUTE6 
 
neuropharmacology focuses on the study of how drugs affect human behavior 
(neuropsychopharmacology), including the study of how drug dependence 
and addiction affect the human brain.
 [3]
  
     Neuropsychopharmacology may be defined as the branch of inter disciplinary 
neuroscience devoted to the study of drugs that have an effect on the nervous tissue and alter 
the behaviour. Neuropharmacology deals with the study of effects of the drug on nerve cells, 
their synapses and circuit whereas the study of effects of drugs on behaviours, including 
emotional and cognitive mental activities, is Psychopharmacology. It associates the frontiers 
of fundamental neuroscience to the management of psychiatric and neurological diseases. 
This branch of science seeks to comprehend how drugs selectively affect the CNS to induce 
sleep, relieve pain, reduce fever, suppress muddled movement, prevent seizures or enhance 
attention. Neuropsychopharmacology seeks to understand how drugs can treat mania, 
anxiety, schizophrenia or depression without disturbing the consciousness. This field seeks to 
uncover the biological basis for intricate mental states. The goal of this field is not only to 
understand the nature of the alterations in biology which direct to distorted emotions and 
thought processes, but also to develop therapeutically priceless specific molecules which 
regulate the specific biologic underpinnings- namely, the as yet vague sequences of multi-
neuronal interactions by which the behaviors emerge
[4]
. 
 Advance in modern science and technology have contributed to an enormous 
development in the quality of human life. However, modern life stresses are responsible for 
the surge in incidence of variety of psychiatric disorder. Drugs that are currently used in 
managing different neuropsychiatric and neurological disorders like anxiety, depression, 
schizophrenia, epilepsy, Parkinsonism either  have severe side effects or posses inauspicious 
drug-drug/drug-food interactions. Moreover, the western system of medicine pays no heed to 
the fundamental problems and depends on drug treatment to cure the symptoms. The western 
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restorative treatment fails to tackle the huge diversity among patients. In this context, 
Ayurvedic treatment, which considers a patient‟s entire body-mind-spirit relationship and bio 
individuality which aims to look at the root cause of the disease and it‟s relation with the 
lifestyle, thoughts and beliefs of the person (vital energy of the patient), have attained 
widespread fame in treating the neurologic disorders than the western system of 
medicine
[5]
. Molecular neuropharmacology involves the study of neurons and their neuro-
chemical interactions, with the overall goal of developing drugs that have beneficial effects 
on neurological function. Both of these fields are closely connected, since both are concerned 
with the interactions of neurotransmitters,  neuropeptides,  neurohormones, 
 neuromodulators, enzymes, second messengers,  co-transporters, ion channels, and receptor 
proteins in the central and peripheral nervous systems.
[3] 
 
Neurotransmission 
 Neurotransmission may be defined as the process of transfer of impulses between 
neurons and Neurotransmitters are those biochemical substances responsible for the 
transmission of nerve signals across a synapse between two neurons. 
            The Central Nervous System uses a wide variety of Neurotransmitters including both 
Excitatory and Inhibitory chemical transmitters including: 
1. Biogenic Amines 
 Dopamine 
 Norepinephrine 
 Epinephrine 
 Serotonine 
 Histamine 
2. Amino Acids 
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 Glutamic Acid 
 Aspartic Acid 
 Gama Amino Butyric Acid 
 Glycine 
3. Peptides 
 Angiotensin 
 Endorphins 
 Vasopressin 
 Substance P etc. 
4. Others  
 Purines (Adenosine & Adenosine Triphosphate) 
 Nitric Oxide 
Acetylcholine and Monoamines are ought to perform specialized regulating functions, 
often limited to explicit structures. The peptides regulate neuronal function by themselves or 
in concert with other neurotransmitters and execute specialized functions mainly in 
hypothalamus.  
 
Table-1: Some Neurotransmitters found in Nervous system 
 
         Name 
       
        Effects 
 
Receptor    
subtype 
 
 Receptor 
motif 
 
                Mechanism 
AMINES 
Acetylcholine 
 
 
 
 
Both excitatory 
& inhibitory 
 
 
 
 
Nicotinic 
Muscarinic 
 
 
 
Ionotropic 
Metabotropic 
 
 
 
 Na+, K+,Ca2+ conductance 
 IP3/DAG/Ca
2+
 
  cAMP,  K+ conductance 
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Norepinephrine 
 
 
 
 
Dopamine  
 
 
 
Serotonin 
(5HT) 
 
 
 
Histamine  
Both excitation 
& inhibition in 
the brain stem 
 
 
Predominantly  
Inhibitory 
 
 
Both excitatory 
& inhibitory 
 
 
 
Mainly 
inhibitory. 
Functions 
uncertain. 
α1 
α2 
β1 , β2, β3 
 
 
D1, D5 
D2, D3, D4  
 
 
5HT1 
5HT2 
5HT3 
5HT4-7 
 
H1 
H2 
H3 
Metabotropic 
Metabotropic 
Metabotropic 
 
 
Metabotropic 
Metabotropic 
 
 
Metabotropic 
Metabotropic 
Ionotropic 
Metabotropic 
 
Metabotropic 
Metabotropic 
Unknown  
 
 IP3/DAG/Ca
2+
 
 cAMP,   K+, 
Ca
2+
conductance 
 cAMP 
 
cAMP 
cAMP     K+,                            
Ca2+ conductance 
 
cAMP,    K+ conductance 
 IP3/DAG/Ca
2+
 
  Na+, K+,Ca2+ conductance 
cAMP 
 
 IP3/DAG/Ca
2+
 
cAMP 
Unknown 
 
 
 
Amino Acids 
Glycine  
 
 
Glutamate & 
Aspartate  
 
 
 
 
Gama-
aminobutyric 
acid (GABA) 
 
 
 
Inhibitory 
 
 
 
Excitatory  
 
 
 
 
 
Inhibitory 
 
 
α ,βsubunits  
 
 
 
AMPA 
Kainate 
NMDA 
mGlu(1-7) 
 
 
GABAA 
GABAB 
 
Ionotropic 
 
 
 
Ionotropic 
Ionotropic 
Ionotropic 
Metabotropic 
 
 
Ionotropic 
Metabotropic 
 
 
Cl- conductance 
 
 
 
  Na+, K+ conductance 
  Na+, K+ conductance 
  Na+, K+,Ca2+ conductance 
cAMP 
  IP3/DAG/Ca
2+
 
 
cAMP 
Cl- , K+ conductance[6][7] 
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NEUROLOGIC DISORDERS 
 Human beings accomplish competence through multifaceted integrated processes. The 
major neural system which account for this competence includes; sensory, motor and 
cognition systems. Alteration in all of this or any one of them has an effect on competence. 
Some of the disorders associated with disturbances in the activity of neurological system 
include: 
 Convulsion  
 Anxiety 
 Depression [8] 
CONVULSION 
A convulsion is a medical condition where body muscle contract and relax rapidly 
and repeatedly, resulting in an uncontrolled shaking of the body
. 
Because epileptic seizure is 
often a symptom of convulsion , the term convulsion is sometimes used as a synonym for 
seizure .However ,not all epileptic seizure leads to convulsions are caused by epileptic 
seizures
[9]
. 
  An epileptic seizure is a transient occurrence of signs and/or symptoms due to 
abnormal excessive or synchronous neuronal activity in the brain. Epilepsy is one of the most 
common neurological conditions, occurring in about 1% of the global population. It is second 
most common disorder after stroke. Several new drugs have been licensed and many others 
are in various stages of development, e.g. remacemide, lamotrigine, flunarizine, loreclezole 
and levetiracetam. Despite optimal use of the 16 antiepileptic drugs marketed in the United 
States, many patients with epilepsy fail to express seizure control and others do so only at the 
expense of significant toxic side effects. Phenytoin, Carbamazepine and Sulfamate topiramate 
(TPM) are antiepileptic drugs that have been clinically effective against different types of 
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seizures
[10]
. Estimates suggest that available medication controls the seizures in only 50% of 
patients or decreases the incidence in only 75% of patients. The search for antiepileptic 
agents with more selectivity and lower toxicity continues to be an area of investigation in 
medicinal chemistry. The mechanisms of action of the antiepileptic drugs (AEDs) consist in 
the blockade of voltage-dependent Na+ channels or T-type Ca+2 channels, inhibition of 
glutamatergic transmission and facilitation of γ-amino-butyric acid (GABA) inhibitory 
neurotransmission.
[11]
 
SYMPTOMS AND CAUSES  
  When a person is having a convulsion, they may experience several different 
symptoms. These may include: a brief blackout, confusion, drooling, loss of bowel/bladder 
control, sudden shaking of entire body, uncontrollable muscle spasms, temporary cessation of 
breathing, and many more. Symptoms usually last from a few seconds to around 15 minutes. 
If someone has a fit like this, it is advised to make sure they don't fall and injure themselves, 
cushion their head and loosen any restricting clothing/jewellery, and also call for medical 
help. Do not try to pin/hold them in place, as this could possibly cause harm or injury to the 
individual. Do not place anything between the person's teeth during a seizure (including your 
fingers).
 [12] 
 
All forms of epilepsy have their origin in the brain. The different types of epilepsies 
are not based on a single underlying mechanism, but are multifactorial in origin. Epilepsy 
results when many neurons in union, under a high excited stage, deliver massive discharges 
abolishing a finely organized pattern of the integrative activity of the brain. John Jackson 
proposed that these seizures are caused by occasional, sudden, excessive, rapid and local 
discharges of grey matter and once initiate by the abnormal focus, the seizures attack the 
neighbouring normal brain resulting into generalized convulsions. This abnormal focus may 
originate as a result of local biochemical changes, ischemia or the loss of vulnerable cell 
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inhibito0ry systems. However, certain physiological changes may trigger the focus and thus 
facilitate the spread of abnormal electrical activity to normal tissue. Such factors include 
 
a. Changes in blood glucose concentration 
b. Plasma pH   
c. Total osmotic pressure and electrolytes composition of extra cellular fluids  
d. Fatigue   
e. Emotional stress  
f. Nutritional deficiency  
g. Trauma, infection meningitis, brain tumors, cerebrovascular disease or metabolic  
abnormalities. 
h. Epileptic seizures of unidentified cause are known as primary or idiopathic 
epilepsy while epileptic attacks of known causes are called as secondary or 
symptomatic epilepsy. 
[11]
 
Classification Types 
[11]
  
[A] Generalized epilepsy: Once initiated, it spreads quickly into the entire or at least the 
greater part of the brain. It can be further classified into 
i. Tonic clonic seizures (grandmal type): It has a close resemblance with electrically 
induced convulsions where the mass stimulation of cortical neurons occurs. As the 
name indicates, initially there is a generalized tonic activity followed by clonic phase.  
ii. Absence or minor seizures (petitmal): It is reported to occur mainly in young 
children between the ages of 6 to 14 years. Seizures generally disappear 
spontaneously after adolescence. 
iii. Myoclonic seizures: The attack characterized by the jerky muscular movements of 
head, limbs or body as a whole. The etiology of attack is not known and is suppose to 
be due to brain damage. 
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iv. Infantile spasms: The attack sometimes begins with a cry and is often associated 
with memory unconsciousness.  
[B] Partial or focal epilepsy: In this type the initial neuronal discharge originates from a 
specific limited cortical area. It can further be classified as 
i. Complex partial seizures (psychomotor or lobe seizures); It usually originates in the 
anterior temporal lobe and is characterized by hallucinations, fear, hate or other 
emotional and behavioral abnormalities.  
ii. Motor epilepsy: Only one, entire side is affected, consciousness is not lost. Motor 
epilepsy is mainly witnessed in child hood and is due to more limited cortical 
abnormalities. 
Mechanisms  
A. Neuronal Sites of Action of antiepileptics – Antiepileptic drugs acting upon 
neuronal site have been shown by Fig.1.  
B. Sites of Action of antiepileptic in GABAergic Synapse - Antiepileptic drugs acting 
through GABAergic Synapse have been shown by Fig.2. 
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Fig 1. Neuronal sites of action of antiepileptics 
  
 
 
 
 
 
 
 
 
 
 
         INTRODUCTION                                                             
DEPT.OF PHARMACOLOGY, THE ERODE COLLEGE OF PHARMACY & RESEARCH INSTITUTE15 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig.2. Sites of action of antiepileptics in GABAergic synapse 
 
EXPERIMENTAL MODELS FOR CONVULSION 
Simple Partial Seizure Models. 
 
i. Cortically Implanted Metals 
 
ii. Aluminum, Cobalt, Zinc 
Complex Partial Seizure Model. 
i. Kainic Acid Administration (KA) 
ii. Repetitive Electrical Stimulation (“Kindling”) 
Generalized Tonic Clonic Seizure Models. 
i. Maximum electroshock 
ii. Pentylentetrazol 
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Generalized Partial Seizure Models. 
i. Penicillin 
ii. Bicuculine 
Generalized Absence Seizure Models. 
i. Audiogenic seizures in mice. 
ii. Genetic: Photosensitive Papio papio 
Status epilepticus. 
i. Pilocarpine 
SIMPLE PARTIAL SEIZURE MODEL 
Aluminium hydroxide model 
The first report on aluminium (Al) and epileptic seizures was documented by 
Kopeloff and collaborators in 1942, who observed that the application of alumina cream to 
the cerebral cortex of experimental animals resulted in the development of convulsive 
seizures. Later, Kopeloff and his group described a model of epileptogenesis, using 
aluminium hydroxide Al (OH)3. This was classified within the models of simple partial 
seizures, of the focal type. Application of 100 μL of a 3-5 % solution of Al (OH)3 on the 
cerebral cortex (Cx), causes recurring seizures after 2 months. Applying alumina cream on 
the motor cortex of cats Produced similar effects, showing that it can produce convulsions 
when applied directly. In a study in which Al gel (30-40 µL) was applied on the sensorimotor 
cortex, animals displayed convulsive seizures in a spontaneous manner, and this was 
observed for 70 days after the application of aluminium. Al is an option when studying focal 
experimental epilepsy, but when applied on the temporal lobe of monkeys, it can simulate a 
temporal lobe crisis similar to what is seen in humans. Reports indicate that this model can 
produce an important loss of the neuronal dendrites in the epileptic focus, as well as gliosis, 
therefore, an increase in the number of glial connections. Along with the cellular changes 
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produced by this model, there is a lower number of GABAergic neurons and a drop in the 
number of positive terminals for glutamate decarboxylase (GAD) around the epileptic focus. 
This model has been used in research for epilepsy drugs, such as diphenylhidantoine and 
pentobarbital, where these drugs have shown an antiepileptic effect. 
Cobalt model 
Cortical implantation of cobalt can produce chronic or subacute models of recurrent 
seizures in animals. GABA receptors have been found to be decreased in the region of cobalt 
foci of rat motor cortex, 2-3 weeks after establishment of the focus. Furthermore in the 
unilateral cobalt model, the lack of anatomic differences in the white or gray matter outside 
the areas of MR signal loss caused by cobalt suggests no widespread cerebral injury. 
COMPLEX PARTIAL SEIZURE MODEL 
Kainic acid (KA) model 
In 1970, Shinozaki and Konishi showed that kainic acid (KA)  Systemic 
administration of the appropriate dose of KA induces ‗wet dog shakes„, generalized tonic-
clonic convulsions, teeth chattering and altered motor activity including an initial 
hypoactivity which transforms to a hyperactivity at later stage. Neurodegenerative occurs in 
the pyramidal layer of CA3 area of hippocampus and in the piriform cortex as early as 3 
hours following injection. At this time point, a positive correlation exists between the dose of 
KA and the extent of the acute neurochemical changes including increases of 3, 4- 
dihydroxyphenylacetic acid and decrease in noradrenaline levels in all brain regions 
investigated. By 13 hours to 2 weeks, neuronal somata degenerate and disappear in areas such 
as the olfactory cortex and parts of the amygdaloid complex, hippocampal formation, 
thalamus and neocortex. 
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Kindling animal model: 
Kindling is a model of epilepsy produced by repeated administration of an initially 
subconvulsive electrical or chemical stimulus that results in an increase in seizure activity, 
culminating in a generalized seizure.  In rats the electrode is implanted in the right amygdale 
for electrical stimulation. Animal is allowed to recover from surgery for a minimum of 1-2 
weeks; otherwise the sensitivity of the animals to kindling is lowered. Then daily electrical 
stimulus trains are applied via the electrode using either a fixed current strength (400-500 μA, 
1 m sec monophase square wave pulses for 1 sec with 50 or 60/sec frequency) or using the 
individual threshold current to induce after discharge at the site of stimulation.  During the 
daily electrical stimulation of amygdala, seizures develop into five stages: 
Class-1: Immobility, eye closure, twitching of vibrissae, stereotypic sniffing 
Class-2: Facial clonus and head nodding 
Class-3: Facial clonus, head nodding and forelimb clonus 
Class-4: Rearing, often accompanied by bilateral forelimb clonus 
Class-5: Rearing with loss of balance and failing accompanied by generalized clonic seizures. 
Rats are said to be fully kindled when enhanced sensitivity, as evidenced by class five 
seizures has developed. If the stimulation is continued for a few weeks, rats develop 
‗spontaneous„ epileptic seizures that persists for as long as 7 months following termination of 
the stimulation. 
Lothman et al described an alternate method for producing the fully kindled state in 
rats: the rapidly recurring hippocampal seizure (RRHS) model and Gupta YK et al  described 
an alternative method for Kindling; a subconvulsive dose of PTZ (35 mg/ kg body  was 
injected intraperitoneally on every second day for (43 days as 22 injections). The PTZ 
injections were stopped when the animals showed adequate kindling. 
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GENERALIZED TONIC CLONIC SEIZURE MODELS 
Electroshock seizure model 
Electrical stimulation of the brain by placing electrodes on the cornea or ears has been 
used to induce motor convulsions that depend on the intensity of the stimulation. Tonic-
clonic convulsions are produced by high electroshock currents, between 25 mA to 150 mA 
and 50 Hz with duration of 2 ms. The intensity used depends on the animal, for example, in 
mice, a 50 mA current applied through a corneal electrode for 0.2 s, as described elsewhere, 
is sufficient to produce a convulsive crisis. Electrical stimulation current strengths tend to 
vary. Large portions of the brain are stimulated with electroshock stimulation, causing 
generalized neural discharges. Daily repetitive low current electroshock stimulation on a 
daily basis induces limbic kindling; evidence shows that responses are produced mainly in 
granule cells of the Hp, and also in the neocortex and pyriform cortex. Also, electroshock-
induced behavioural changes persist for at least 28 days. Microinjection of GABA has an 
anti-convulsive effect in rats with seizures induced by electroshock. Different antiepileptic 
drugs were later tested using this model, such as carbamazepine and valproic acid. 
Lamotrigine and oxcarbazepine inhibited seizures by 50% in this model.  
Pentylentetrazol model 
PTZ is a tetrazole derivative with consistent effect in a large number of animal species 
like mice, rats, cats, primates etc. It is believed to act by antagonizing the inhibitory 
GABAergic neurotransmission. PTZ test is used for screening of drugs affective in petit mal 
epilepsy or tonic clonic seizures. In the s.c. PTZ (or metrazol) seizure test, the convulsive 
dose of PTZ inducing a clonic seizure of at least 5 s duration in 97% of the animals (CD97) is 
subcutaneously injected and animals are observed for a postinjection period of usually 30 min 
for the occurrence of such a “threshold” seizure. The test is thought to be predictive of 
anticonvulsant drug activity against nonconvulsive (absence or myoclonic) seizures. Drug 
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effective in petit mal epilepsy like ethosuximide, vaproic acid are effective while phenytoin , 
carbamazepine are not effective in the PTZ  model. 
GENERALIZED PARTIAL SEIZURE MODELS 
Penicillin model 
One of the most popular models o study simple partial seizure has been the 
application of „topical‟ convulsants such as the antibiotic penicillin. How-ever, penicillins has 
been applied in models of „systemic focal epileptogenesis‟ andmodels of generalized tonic-
clonic and absence seizure. The convulsive properties of penicillin were first observed by 
Walker and Jhonson, 
 When penicillin is applied topically to exposed rat or cat cortex through a cottonoid 
pledget (soaked in 1.7-3.4 mM penicillin), acute focal seizures develop. Regionally placed 
electrodes records recurring interictal spikes that resemble human interictal spikes within a 
few minutes of application. Initial descriptions of the „paroxysaml depolarisation shift‟, 
considered to be a hallmark of epilepsy, were based upon intracellular recordings from from 
penicillin foci in rat neocortex. This models has also been considered suitable for study of 
spread of seizure activity. 
 Parental administration of penicillins produces generalized seizures in cats and mice. 
Seizures induced by parenteral penicillin in rat bear little  resemblance of clinical absences. 
However, parenteral penicillin G administration (≥300,000 units intramuscular (i.m)/kg)  in 
cat results in recurrent episodes of arrested activity, starting, myoclonus, studied. While 
diazepam, carbamazepines and phenytoin have a high protective efficacy, phenol-barbital has 
intermediate effectiveness; the antiabsence agents, valproate and ethosuximide, display a low 
effectiveness. 
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Gaba abstinence model 
This model was originally described by Snead and is a focal epilepsy model, which 
can be induced by injecting GABA in the motor cortex. It is known that animals receiving 
chronic treatment with this amino acid, and then had it removed; display an 
electrocorticographic activity pattern of epilepsy. In this model, peaks of activity are 
displayed in the waves of the EEG, from 200 to 700 µV, with frequencies from .05 to 3 
cycles per second in the motor cortex, followed by mioclonic automatisms of the fore and 
hind limbs . According to previous descriptions, increases in the concentration of glutamate 
antagonists are accompanied by neurotoxic effects. 
GENERALIZED ABSENCE SEIZURE MODEL 
Audiogenic seizure model 
Audiogenic seizure–prone mice have proved useful for identifying potential AEDs. 
When these mice are exposed to high-frequency (10–20 kHz) and high intensity (90–120 dB) 
sound, they exhibit wild running, followed by generalized clonic–tonic seizures. With some 
seizuresusceptible strains of mice, the seizure focus must be established with a priming 
stimulus of high intensity sound. In several strains of mice, seizure susceptibility changes 
with age, usually reaching a maximal level between 2 and 4 weeks of life; however, the 
Frings and O„Grady strains of mice may retain their susceptibility to seizures into their adult 
life. The most commonly used strain of audiogenic seizure–prone mice for anticonvulsant 
identification is the DBA/2J. It is an inbred strains of the house mouse (Mus musculus), is the 
most studied strains of audiogenic seizure susceptible mice. 
STATUS EPILEPTICUS 
Lithium-pilocarpine model 
Pilocarpine hydrochloride is an agonist of muscarinic Ach receptors expressed in the 
Hp, and is known to produce seizures by increasing the activation of these receptors.  One 
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recently popularized model of status epilepticus is the lithium-pilocarpine model. In this 
model rats are pretreated with lithium chloride. At least 20 h later the cholinergic agent 
pilocarpine is given. Generalize clonic or tonic-clonic seizure activity begins about 30 min 
after administration of pilocarpine, and continues for several hours. The EEG pattern displays 
a progression very similar to the stages seen in human status epilepticus. Chronic 
pretreatment for one month with daily lithium reduces the convulsant threshold of pilocarpine 
26-fold. In lithium-pilocarpine treated adult rats, neuronal damage and neuronal death 
develops mainly in the hippocampus, the hilus of the dentate gyrus, the piriform and 
entorhinal cortices, the amygdala, the neocortex and the thalamus. Also, lithium-pilocarpine 
treatment leads to hippocampal damage that is typically observed in the CA1 and CA3 
pyramidal cell layers and the hilus of the dentate gyrus in mice with status epilepticus.
[13]
 
ANTI-CONVULSANT  
CLASSIFICATION OF ANTI-CONVULSANT DRUGS 
1)Action on Ion Channels 
Sodium channels: 
i. Phenytoin 
ii. Carbamazepine 
iii. Topiramate 
iv. Valproic acid  
Calcium channels: 
i. Ethosuximide 
ii. Valproic acid 
2) Enhance GABA Transmission  
 Benzodiazepines 
i. Diazepam 
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ii. Clonazepam 
iii. Lorazepam 
 Barbiturates 
i. Valproic acid  
ii. Gabapentin 
iii. Vigabatrin 
iv. Topiramate 
v. Felbamate 
3) Inhibit EAA Transmission  
i. Felbamate 
ii. Topiramate 
CLASSIFICATION OF CLASSICAL / NEWER : 
Classical Newer 
i.  Phenytoin        i.  Lamotrigine 
ii.  Phenobarbital   ii.  Primidine 
iii.  Topiramate iii.  Carbamazepines 
iv.  Tiagabine iv.  Ethosuximide   
v.  Vigabatrin v.  Valproic acid 
vi.  Oxycarbazepine vi.  Trimethadione 
  vii.  Levevitracetam 
  viii.  Fosphenytoin 
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Established & Newer Antiepileptic Drugs  
The currently used therapy of epilepsy includes various drugs that act through 
different mechanisms. There are several classes of antiepileptic drugs (AEDs) that have been 
divided on the basis of their chemical structure. Different established AEDs and newer 
antiepileptic drugs along with the drugs in pipeline are summarized in Table 1 and 2. 
 Table-2: General Description of Established Antiepileptic Drugs 
Drug Structure Clinical Uses Mechanism 
 
Phenytoin 
(Dilantin) 
 
 
 
Partial and 
tonic-clonic 
Prolongs closing of 
inactivating gate of 
sodium channels of 
excitatory NT receptors in 
the CNS 
Carbamazepine                                   
(Tegretol) 
 
Partial and 
tonic-clonic 
Prolongs closing of 
inactivating gate of 
sodium channels of 
excitatory NT receptors in 
the CNS 
Phenobarbital 
(Luminal®) 
 
Partial and 
tonic-clonic 
Facilitates the inhibitory 
action of GABA, 
increases the duration of 
chloride channel opening 
at GABA-A receptors 
Ethosuximide 
(Zarontin®) 
 
Absence 
seizures 
Inhibits low-threshold T-
type calcium currents in 
thalamic neurons 
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Valproic acid 
(Depakene®) 
Divalproex Na 
(Depakote®) 
 
Partial and 
tonic-clonic and 
absence seizures 
Prolongs inactivation of 
sodium channels of 
excitatory NT receptors in 
CNS Inhibits low-
threshold T-type calcium 
currents in thalamic 
neurons. Increases the 
amount of GABA in CNS. 
Increases GAD activity. 
Decreases GABA-T and 
succinic semialdehyde 
dehydrogenase activity 
Clonazepam 
(Klonopin®) 
 
Absence and 
myoclonic 
Facilitates the inhibitory 
actions of GABA 
Diazepam (Valium®) 
 
 
Status 
epilepticus 
Increases the frequency of 
opening of chloride 
channel of GABA-A 
receptor 
Lorazapam (Ativan®) 
 
Status 
epilepticus 
Increases the frequency of 
opening of chloride 
channel of GABA-A 
receptor 
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Chlorazepate 
(Tranxene®) 
 
Partial 
myoclonic, 
absence. 
Increases the frequency of 
opening of chloride 
channel of GABA-A 
receptor 
Trimethadione 
 
Absence 
Inhibits low-threshold T-
type calcium currents in 
thalamic neurons 
Bromide                    Br - 
Epilepsy in 
porphyrias. 
Not known 
 
Table-3: General Description of New Anticonvulsants 
A) Marketed Drugs 
DRUGS STRUCTURE MECHANISM 
CLINICAL 
USES 
SIDE 
EFFECTS 
Eslicarbazepin
e 
(Zebinix; 
Exalife) 
 
Novel voltage 
gated Na
+
-
channel blocker 
As adjunct in 
partial onset 
seizures;also in 
bipolar disorders 
and trigerminal 
neuralgia 
 
- 
Felbamate 
(Felbatrol) 
 
 
Possible blockade 
of NMDA 
receptor 
Partial seizures 
lennox-gastaut 
syndrome 
Server hepatitis 
aplastic anemia 
         INTRODUCTION                                                             
DEPT.OF PHARMACOLOGY, THE ERODE COLLEGE OF PHARMACY & RESEARCH INSTITUTE27 
 
Flunarizine 
(Sielium) 
 
Ca
++ - 
Channel 
blocker with 
calmodulation 
binding property 
and Histamine 
blocking activity 
 
 
- 
 
 
- 
Gabapentin 
(Neurontin) 
  
Increase the 
release of GABA 
Adjunct  drug for 
partial and 
generalized 
toniclonic 
seizures 
Somnolence 
dizziness      
Ataxia   Headache 
Lacosamide 
(Vimpat) 
 
Enhances slow 
activation voltage 
gated Na
+ 
Channel 
 
- 
 
- 
Lamotrigine 
(Lamictal) 
 
Prolongs closing 
of inactivating 
gate of Na
+
 
channel 
Partial seizures 
Dizziness 
headache diplopia  
somnolence    
skin rashes 
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Levitracetam 
(Keppra) 
 
 
Binds to synaptic 
vesicles protein 
SV2A thereby 
impeding nerve 
conduction across 
synapse 
Adjunct for 
partial seizures 
with or without 
secondary 
generalization 
Minimal 
dowsiness 
Anxiety Amnesia 
Oxcabazepine 
(Trileptal) 
 
Blockade of 
voltage sensitive 
sodium channels 
Partial seizures 
with or without 
generalization 
CNS side effects, 
hematological 
abnormalities and 
effects on drugs 
metabolizing 
enzymes are less 
than 
carbamazepines 
Pregabalin 
(Lyrica) 
 
 
Not Known 
For neuropathic 
pain and adjunct 
therapy for partial 
seizures 
- 
Tiagabine 
(Gabatril) 
 
Inhibition of 
GABA uptake 
Adjunct for 
partial seizure 
Nervousness 
Dizziness 
Tremors 
Depression 
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Topiramate 
(Topamax) 
 
 
 
Prolongs closing 
of inactivating 
gate of Na
+
 
channel, 
potentiates the 
GABA effects 
and blocks 
AMPA receptors 
Partial seizures 
Drowsiness 
Parathesia 
Confusion 
 
Vigabatrin 
(sabril) 
 
Irreversible 
inhibitor of 
GABA 
aminotransferase 
(GABA-T) 
Partial seizures 
Drowsiness 
Dizziness 
Weight gain 
Psychosis 
Zonisamide 
(Zonegran) 
 
Inactivation of 
Na
+  
And ca
++  
channels 
Partial and 
generalized tonic-
clonic seizures 
Drowsiness 
Cognitive 
Impairment 
 
Perampanel 
(E2007) 
 
Selective 
antagonist for the 
AMPA sub type 
of inonotrpic 
glutamate 
receptors 
Drug suggests 
efficacy and 
safety in 
refractory 
epilepsy 
Dizziness 
Drowsiness 
Irrtabolity 
Headache 
Falls 
Ataxia
[11] 
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PHENYTOIN : 
          Phenytoin,(Dilantin) , is an anti-seizure medication. It is useful for the prevention of 
tonic-clonic seizures, partial seizures, but not absence seizures. The intravenous form is used 
for status epilepticus that does not improve with benzodiazepines. It may also be used for 
certain heart arrhythmias or neuropathic pain. It can be taken intravenously or by mouth. The 
intravenous form generally begins working within 30 minutes and is effective for 24 hours. 
Blood levels can be measured to determine the proper dose.
 
Structure of phenytoin  
(5,5-DIPHENYHYDANTOIN) 
 
           Common side effects include nausea, stomach pain, loss of appetite, poor 
coordination, increased hair growth, and enlargement of the gums. Potentially serious side 
effects include sleepiness, self harm, liver problems, bone marrow suppression, low blood 
pressure, and toxic epidermal necrolysis. There is evidence that use during pregnancy results 
in abnormalities in the baby. It appears to be safe to use when breastfeeding. Alcohol may 
interfere with the medication's effects.  
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MECHANISM OF ACTION 
             Phenytoin is believed to protect against seizures by causing voltage-dependent    
block of voltage gated sodium channels. This blocks sustained high frequency repetitive 
firing of action potentials.   This is accomplished by reducing the amplitude of sodium-
dependent action potentials through enhancing steady state inactivation. Sodium channels 
exist in three main conformations: The resting state, the open state, and the inactive state 
                                  Fig-3 Mechanism of action Phenytoin 
. 
             Phenytoin binds preferentially to the inactive form of the sodium channel. Because it 
takes time for the bound drug to dissociate from the inactive channel, there is a time 
dependent block of the channel. Since the fraction of inactive channels is increased by 
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membrane depolarization as well as by repetitive firing, the binding to the inactive state by 
phenytoin sodium can produce voltage-dependent, use-dependent and time-dependent block 
of sodium-dependent action potentials.  
             The primary site of action appears to be the motor cortex where spread of seizure 
activity is inhibited.  Possibly by promoting sodium efflux from neurons, phenytoin tends to 
stabilize the threshold against hyper excitability caused by excessive stimulation or 
environmental changes capable of reducing membrane sodium gradient. This includes the 
reduction of post-tetanic potentiating at synapses which prevents cortical seizure foci from 
detonating adjacent cortical areas. Phenytoin reduces the maximal activity of brain stem 
centers responsible for the tonic phase of generalized tonic-clonic seizures. 
Pharmacokinetics  
                  Phenytoin elimination kinetics show mixed-order behaviour at therapeutic 
concentrations. A small increase in dose may lead to a large increase in drug concentration as 
elimination becomes saturated. The time to reach steady state is often longer than 2 weeks. 
Therapeutic uses 
Seizures  
a) Tonic-clonic seizures:  Mainly used in the prophylactic management of tonic-clonic 
seizures with complex symptomatology (psychomotor seizures). A period of 5–10 
days may be required to achieve anticonvulsant effects.  
b) Focal seizures: Mainly used to protect against the development of focal seizures with 
complex symptomatology (psychomotor and temporal lobe seizures). Also effective 
in controlling partial seizures with autonomic symptoms.  
c) Absence seizures: Not used in treatment of pure absence seizures due to risk for 
increasing frequency of seizures. However, can be used in combination with other 
anticonvulsants during combined absence and tonic-clonic seizures. 
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d) Seizures during surgery: Used as prevention and treatment of seizures occurring 
during and after neurosurgery.   
e)  Status epilepticus: Considered after failed treatment using a benzodiazepine due to 
slow onset of action. 
Other:   
     f)  Abnormal heart rhythms: may be used in the treatment of ventricular tachycardia and 
sudden episodes of atrial tachycardia after other antiarrhythmic medications or cardioversion 
has failed. It is a class 1b antiarrhythmic. 
Special considerations:   
Monitoring plasma concentrations:  
g) Pregnancy: Pregnancy Category D due to risk of fetal hydantoin syndrome and fetal 
bleeding. However, optimal seizure control is very important during pregnancy so 
drug may be continued if benefits outweigh the risks. Due to decreased drug 
concentrations during pregnancy, dose of phenytoin may need to be increased if only 
option for seizure control. 
h) Breast feeding: The manufacturer does not recommend breast feeding because low 
concentrations of phenytoin are excreted in breast milk . 
i) Liver disease: Do not use oral loading dose. Consider using decreased maintenance 
dose. 
j) Kidney disease: Do not use oral loading dose. Can begin with standard maintenance 
dose and adjust as needed.
 [14]
 
DEPRESSION  
          Depression is a common mental disorder that presents with depressed mood, loss of 
interest or pleasure, feelings of guilt or low self-worth, disturbed sleep or appetite, low 
energy, and poor concentration. These problems can become chronic or recurrent and lead to 
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substantial impairments in an individual's ability to take care of his or her everyday 
responsibilities. At its worst, depression can lead to suicide, a tragic fatality associated with 
the loss of about 850 000 lives every year. Depression is the leading cause of disability as 
measured by YLDs (Years Lived with Disability) and the 4th leading contributor to the 
global burden of disease (DALYs- Disability Adjusted Life Years) in 2000. By the year 2020, 
depression is projected to reach 2nd place of the ranking of DALYs calcuated for all ages, 
both sexes. Today, depression is already the 2nd cause of DALYs in the age category 15-44 
years for both sexes combined. Depression occurs in persons of all genders, ages, and 
backgrounds.   
DIAGNOSIS 
            Currently, no laboratory test can be used to diagnose depression. Depression is 
diagnosed based on your reported symptoms, signs that your doctor observes while 
interviewing you, your medical history and your family's medical history. Criteria outlined in 
a handbook called the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV) are 
used in making the diagnosis. According to the DSM-IV, a person who suffers from major 
depressive disorder must either have a depressed mood or a loss of interest or pleasure in 
daily activities consistently for at least a two week period. This mood must represent a 
change from the person's normal mood; social, occupational, educational or other important 
functioning must also be negatively impaired by the change in mood. A depressed mood 
caused by substances (such as drugs, alcohol, medications) or which is part of a general 
medical condition is not considered to be major depressive disorder. Major depressive 
disorder cannot be diagnosed if a person has a history of manic, hypomanic, or mixed 
episodes (e.g., a bipolar disorder) or if the depressed mood is better accounted for by 
schizoaffective disorder and is not superimposed on schizophrenia, schizophreniform 
disorder, delusional disorder or psychotic disorder. 
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SYMPTOMS AND SIGNS  
          The symptoms should not be accounted for by another illness, drugs of abuse or 
prescription medications. Common symptoms of depression are as follows:  
A. Depressed Mood:   
 A person may report feeling "sad" or "empty" or may cry frequently. Children and 
adolescents may exhibit irritability.  
B. Decreased Interest or Pleasure:  
 A person may show markedly diminished interest or pleasure in all, or almost all, 
daily activities.  
C. Weight Changes:  
 Significant changes in weight when not attempting to gain or lose (a gain or loss 
of 5% or more in a month) may be indicative of depression. In children, this may 
also present as a failure to make expected weight gains.  
D. Sleep Disturbances:  
 Insomnia or sleeping too much may be a symptom of depression.  
E. Psychomotor Agitation or Retardation:  
 The person may be observed to be either agitated or restless or physically slowed 
down in their movements.  
F. Fatigue:  
 Deep fatigue or a loss of energy is a symptom of depression.  
G. Feelings of Worthlessness or Guilt:  
 A depressed person may feel that they have no value or they may feel 
inappropriately guilty about things they have no control over.  
H. Brain Fog:  
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 A depressed person may have a diminished ability to think, concentrate or make 
decisions. 
CAUSES OF DEPRESSION 
                           The causes of depression are complex. Genetic, biological, and 
environmental factors can contribute to its development. In some people, depression can be 
traced to a single cause, while in others; a number of causes are at play. For many, the causes 
are never known. Currently, it appears that there are biochemical causes for depression, 
occurring as a result of abnormalities in the levels of certain chemicals in the brain. While we 
still don't know exactly how levels of these neurotransmitters affect mood, we do know that 
the levels can be affected by a number of factors. Monoamine hypothesis of depression has 
been shown in Fig. 4 
                                  Fig-4   Monoamine hypothesis of depression 
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TYPES OF DEPRESSION  
There are several different types of clinical depression (mood disorders that include 
depressive symptoms): 
A. Major depression:  
It is an episode of change in mood that lasts for weeks or months. It is one of the most 
severe types of depression. It usually involves a low or irritable mood and/or a loss of 
interest or pleasure in usual activities. It interferes with one's normal functioning and 
often includes physical symptoms. A person may experience only one episode of 
major depression, but often there are repeated episodes over an individual's lifetime. 
B. Dysthymia:  
It is less severe than major depression but usually goes on for a longer period, often 
several years. There are usually periods of feeling fairly normal between episodes of 
low mood. The symptoms usually do not completely disrupt one's normal activities. 
C. Bipolar disorder: 
It involves episodes of depression, usually severe, alternating with episodes of 
extreme elation called mania. This condition is sometimes called by its older name, 
manic depression. The depression that is associated with bipolar disorder is often 
referred to as bipolar depression. When depression is not associated with bipolar 
disorder, it is called unipolar depression.  
D. Seasonal depression:  
Which medical professionals call seasonal affective disorder, or SAD, is depression 
that occurs only at a certain time of the year, usually winter, when the number of 
daylight hours is lower. It is sometimes called "winter blues." Although it is 
predictable, it can be very severe. 
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E. Psychotic depression: 
 It refers to the situation when depression and hallucinations or delusions are experienced 
at the same time (co-occur). This may be the result of depression that becomes so severe 
that it results in the sufferer losing touch with reality. Individuals who primarily suffer 
from a loss of touch with reality (for example, schizophrenia) are thought to suffer from 
an imbalance of dopamine activity in the brain and to be at risk of subsequently 
becoming depressed.
[15] 
CLASSIFICATION 
 There are many antidepressant drugs available in the market. The key role is played 
by the time that might be required for a particular outcome of the drug on the individual i.e. 
the response time of a drug can be known in the due course. The commonly used 
antidepressants,  
 Selective serotonin re-uptake inhibitors (SSRIs) 
i. fluoxetine 
ii. sertraline 
iii. citalopram 
iv. Escitalopram 
v. paroxetine 
vi. fluvoxamine 
 Serotonin and norepinephrine re-uptake inhibitors (SNRIs) 
i. Venlafaxine 
ii. Desvenlafaxine 
iii. Duloxetine 
iv. Milnacipran 
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 Monoamine oxidase inhibitors (MAOIs) 
i. Phenelzine 
ii. Isocarboxazid 
iii. Tranylcypromine 
iv. Selegiline 
v. Moclobemide 
 Tricyclic antidepressants (TCAs) 
i. imipramine 
ii. clomipramine 
iii. amitriptyline 
iv. desipremine 
v. trimipramine 
vi. nortriptyline 
vii. protriptylinr 
viii. doxepin 
 Tetracyclic antidepressants 
i. Amoxapine  
ii. Maprotiline 
iii. Bupropion 
iv. Mirtazipine 
 Lithium Salts[16] 
Mechanism of Action 
Neurotransmitters are endogenous chemicals that transmit signals across a synapse 
from one neuron to another 'target' neuron. Brain neurotransmitters might not be secreted in 
adequate amounts to alleviate mood disorders. The chemical's like serotonin, melatonin, and 
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dopamine are the most important in brain for sense. Once the nerves are robbed of those 
neurotransmitters, they can't send messages to different nerves which leads to depression. 
The messages that are passed through the neurons are exhibited as emotions, behavior, 
temperature, appetite, or several alternative functions. The information sent depends on that 
neurons area unit activated and what a part of the brain is excited.  
Low levels of serotonin and norepinephrine within the conjunction area leads to 
depression. Hence medications like antidepressant used to treat this works by increasing the 
number of bound neurotransmitters in that particular part of the brain which enables to 
transmit the message.  
Each type of antidepressant works on brain with little difference, all antidepressant 
medications influence the neurotransmitters how to work in the brain, especially serotonin 
and norepinephrine, thus controlling the balance of the neurotransmitters.  
 
 
Fig-5 general mechanism of action anti depressant 
SSRIs (selective serotonin reuptake inhibitors) and SNRIs (serotonin norepinephrine 
reuptake inhibitors) have different mechanisms of action. SSRI has three different serotonin 
reuptake inhibitors those are fluoxetine, paroxetine and sertraline. These have selective effect 
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for both citalopram and fluvoxamine on the serotonin reuptake pump. It leads to primary 
increase in serotonin at the cell body and dendrites. So, SSRIs act by blocking the serotonin 
reuptake pump (5-HTT). Whereas SNRIs presumably block both 5-HTT and the 
norepinephrine transporter (NET). Blocking these transporters prevents the neuron from 
vacuuming up excess neurotransmitters, permitting a lot of to stay within the synapse and 
stimulate postsynaptic receptors. SSRIs have important effect on NE as well, and the SNRIs 
behave much more like SSRIs.  
We extend levels of all 3 monoamines (serotonin, monoamine neurotransmitter, and 
dopamine), ought to be prescribing MAOIs (monoamine enzyme inhibitors). MAOIs aren't 
re-uptake blockers at all; they increase neurotransmitter levels by inhibiting MAO, associate 
enzyme that breaks down all 3 monoamines. Thus, MAOIs increase the amount of all 3 
neurotransmitters thought crucial in depression, these are efficacy advantage over others.  
Tricyclic and tetracyclic antidepressants ease depression by affecting naturally 
occurring chemical messengers. Cyclic antidepressants usually block the results of 2 
neurotransmitters known as serotonin and norepinephrine these are available in the brain. 
This looks to assist brain cells send and receive messages. The roles these chemicals have 
treat the depression. 
 Serotonin receptor modulators utilized in the treatment of irritable intestine 
syndrome. Serotonin plays a major role within the initiation of peristaltic and humour 
reflexes, and in modulation of visceral sensations.  
Lithium is used for manic depression. Manic-depressive patients expertise severe 
mood changes, starting from associate degree excited or frenzied state to depression or 
unhappiness .  
Until higher models of depression area unit devised, establishing the mode of action 
of antidepressants are trouble. The present focus has been on alterations to straightforward 
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vegetative cell models primarily based around monoamine neurotransmitter and 
vasoconstrictive. Clearly, these models don't seem to be sufficient to fully make a case for the 
clinical effects of antidepressants. Additional complicated models, taking under consideration 
alternative transmitters, adaptive changes at the amount of the sequence
[17] 
IMIPRAMINE (Structure) 
 
Mechanism of action 
            Tricyclic antidepressants (TCAs) are a group of drugs used to treat affective, or 
„mood‟, disorders. Despite being an important group of antidepressant drugs they are not 
ideal, due to a number of unwanted side effects. Side effects of the TCAs include sedation, 
caused by histamine H1 receptor blockade; postural hypotension, due to α adrenoreceptor 
blockade; and blurred vision, dry mouth and constipation, due to muscarinic acetylcholine 
receptor blockade.
[18] 
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                                             Fig-6  Mechanism of action TCAs
 
Pharmacokinetics 
The TCA drugs are well absorbed from the gastrointestinal tract, are extremely lipid 
soluble, and bind extensively to plasma proteins. Their half-lives range from 8 to 89 hours. 
Several days to weeks are required both to achieve steady-state serum levels and for complete 
elimination of these agents from the body. Long half-lives make most of these agents 
amenable to dosing once a day, generally at bedtime. Drug inactivation generally occurs 
through oxidative metabolism by hepatic microsomal enzymes. Tertiary amines are converted 
to secondary amines, which generally possess biological activity and are frequently in serum 
at levels equal to or greater than that of the parent tertiary amine. A second route of 
inactivation includes conjugation of hydroxylated metabolites with glucuronic acid
[19]
. 
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Medical uses 
Depression Mild to moderate: 
Normally advised psychotherapy, cognitive, behavior therapy. If depression is more, 
advised antidepressants.  
If acute therapy is required, effects of antidepressants are not seen for 1-2 months. A 
trial of 2-3 months has to be given. If no effects appear after 3 months, doctor may switch to 
another one or a combination. After patient is stabilized, treatment is given for at least 6-12 
months. If not given for long period, there are higher chances especially of relapse. At times 
recurrences of attacks are seen in sensitive patients. 
 Maintenance therapy is prescribed for longer duration. Studies have not been done 
for more than 5 years.  
In some forms of bipolar disorders, antidepressant use is controversial. In this type, if        
antidepressant is taken, patient may go into mania. Its better to give mood stabilizing agent.        
Choice of antidepressant depends on severity of disease and patient‟s profile.[20] 
ANXIETY  
 Anxiety may be defined as an unpleasant state of mental uneasiness, apprehension, 
nervousness and obsession or concern about something uncertain. The major symptoms 
include; arousal, tenseness, increased autonomic activity like respiration, blood pressure and 
heart rate. Tightness in chest, palpitations, perspirations etc. it is a common symptom in a 
variety of distinct mental illnesses and is a predominant symptom in panic disorders, phobias 
and obsessive compulsive disorder. 
MAJOR TYPES OF ANXIETY INCLUDE:  
Panic disorder:  Psychiatric condition associated with multiple disabling panic attacks. In 
between the panic attacks, an excessive time is spent by the individual in thinking about 
future panic attacks. 
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Generalized anxiety disorder: It is characterized by persistent and excessive worries. The 
patient worries about various life events such as job performances, marital status, money, 
social status etc. 
Posttraumatic stress disorder: Caused due to the exposure of individual to life-threatening 
or terrifying life events. The individual re-experiences the traumatic event as flashbacks or as 
intrusive recollections. 
Obsessive – compulsive disorders: The root cause of the disorder is intrusive, repetitive 
compulsions and / or thoughts. Marked distress is the hallmark of this disorder. There occur 
irrational thoughts and acts which impair normal functioning.  
Classification of Anti-Anxiety 
 Benzodiazepines:  
i. Diazepam 
ii. Lorazepam 
iii. Alprazolam 
 Azapironees:  
i. Buspirone 
 Sedative antihistaminic: 
i. Hydroxyzine 
 Beta blocker: 
i. Propranolol.[21][22] 
 
 
 
         INTRODUCTION                                                             
DEPT.OF PHARMACOLOGY, THE ERODE COLLEGE OF PHARMACY & RESEARCH INSTITUTE46 
 
Benzodiazepines(BZD) 
Diazepam (Structure) 
 
 
 
 
 
 
 Diazepam were  Introduced round 1960 as antianxiety drugs. Since then class has 
proliferated and has gaine popularity over barbiturates as hypnotic and 
sedative as well, because- 
1.BZDs  have a high therapeutic index. Ingestions 20 hypnotic doses does not usually 
endangers  life-there is no loss of consciousness through amnesia occurs) and patient can be 
respiration is not so depressed as to assistance. 
2. Hypnotic doses do not affect respiration or cardiovascular functions. Higher doses 
produce mild respiratory depression and hypotension which is problematic only in patients 
with respiratory insufficiency and cardiac/haemo- dynamic abnormality. 
3.BZDs have practically no action on others body system . Only on i.v. injection the 
BP falls May be marked in an occasional patient) and cardiac contractility decreases. Fall in 
BP in diazepam and lorazepam is due to reduction in cardiac output while that due to 
midazolam is due to decrease in peripheral resistence. The coronary arteries dilate on i.v. 
injection of diazepam. 
4.BZDs cause less distortion of sleep architecture rebound phenomena on 
discontinuation of regular use are less marked. 
5.BZDs do not alter disposition of other drugs microsomal enzyme induction. 
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6.They have lower abuse liability: tolerance is mild psychological and physical 
dependence and withdrawal syndrome are less marked. 
7.A specific BZD antagonist flumazenil is available which can be used in case of 
poisoning. 
Mechanism of action 
Benzodiazepines act preferentially on midbrain ascending reticular formation (which 
maintains wakefulness) and on limbic system (throught and mental functions). Muscle 
relaxation is produced by a primary medullary site of action and ataxia is due to action on 
cerebellum. BZDs act by enhancing presynaptic/postsynaptic inhibition through a specific 
BZD receptor which is an integral part of the GABAA receptor-Cl- channel complex. The 
subunits of this complex form a pentameric transmembrane anion channel (Fig.6) gated by 
the primary ligand (GABA), and modulated by secondary ligands which include BZDs. Only 
the a and alpha subunits are required for GABA action, and most likely the binding site for 
GABA is located on the β subunit, while the α/β subunit interface carrys the BZD binding 
site. The modulatory BZD receptor increases the frequency of Cl channel opening induced by 
sub maximal concentrations of GABA. The BZDs also enhance binding of GABA to GABAA 
receptor.  
The GABAA antagonist bicuculline antagonizes BZD action in a non competitive 
manner. It is noteworthy that the BZDs do not themselves increase o- conductance; have only 
GABA facilitatory but no GABA mimetic action. This probably explains the lower ceiling 
CNS depressant effect of BZDs. The BZD receptor exhibits a considerable degree of 
constitutive activation. As such, it is capable of fine tuning GABA action in either direction. 
While the BZD-agonists enhance GABA induced hyperpolarisation (due to influx of cl- 
ions), and decrease firing rate of neurones, other compounds called BZD-inverse agonist like 
dimethoxyethyl-carbomethoxy-beta-carbolime (DMCM) inhibit GABA action and are 
         INTRODUCTION                                                             
DEPT.OF PHARMACOLOGY, THE ERODE COLLEGE OF PHARMACY & RESEARCH INSTITUTE48 
 
convulsants. The competitive BZD-antagonist  flumazenil blocks the sedative action of BZDs  
well as the convulsant action of DMCM.  
 
 
 
 
Fig - 7: Schematic depiction of GABAA benzodiazepine receptor-chloride channel 
complex 
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Drugs affecting GABAA receptor gated chloride channel 
GABA : Agonist at GABAA site 
Muscimol : Endogenous agonist at GABAA receptor → promotes cl- influx 
Bicuculline    : Competitive antagonist at GABAA receptor 
Picrotoxin : Blocks o- channel noncompetitively; acts on picrotoxin sensitive 
site 
Barbiturate    : Agonist at an allosteric site (? picrotoxin site); prolong GABA 
action; open o- channel 
Alcohol,             
Inhalational 
anaesthetics, 
Propofol 
: Open o- channel directly; allosteric facilitation of GABA 
Benzodiazepine : Agonist at an allosteric BZD site → facilitate GABA action 
Beta –Carboline : Inverse agonist at BZD site → impede GABA action (DMCM)  
Flumazenil : Competitive antagonist at BZD site
[23]
 
 
Pharmacokinetics 
Diazepam can be administered orally, intravenously (must be diluted, as it is painful 
and damaging to veins), intramuscularly (IM), or as a suppository. 
 When administered orally, it is rapidly absorbed and has a fast onset of action. The 
onset of action is one to five minutes for IV administration and 15–30 minutes for IM 
administration. The duration of diazepam's peak pharmacological effects is 15 minutes to one 
hour for both routes of administration. The bioavailability after oral administration is 100%, 
and 90% after rectal administration. Peak plasma levels occur between 30 and 90 minutes 
after oral administration and between 30 and 60 minutes after intramuscular administration; 
after rectal administration, peak plasma levels occur after 10 to 45 minutes. Diazepam is 
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highly protein-bound, with 96 to 99% of the absorbed drug being protein-bound. The 
distribution half-life of diazepam is two to 13 minutes. 
When diazepam is administered IM, absorption is slow, erratic, and incomplete. 
Diazepam is highly lipid-soluble, and is widely distributed throughout the body after 
administration. It easily crosses both the blood–brain barrier and the placenta, and is excreted 
into breast milk. After absorption, diazepam is redistributed into muscle and adipose tissue. 
Continual daily doses of diazepam quickly build to a high concentration in the body (mainly 
in adipose tissue), far in excess of the actual dose for any given day. 
Diazepam is stored preferentially in some organs, including the heart. Absorption by 
any administered route and the risk of accumulation is significantly increased in the neonate, 
and withdrawal of diazepam during pregnancy and breast feeding is clinically justified. 
[24]
  
Medical uses 
Anxiety disorders  
Most commonly clinically significant are:  
1. Traumatic stress 
2. Generalized anxiety disorders –chronic state anxiety even without existing cause 
3. Panic disorder -patient avoids situations he may feel might go into panic  
4. Social anxiety disorder –patient avoids social interaction  
 Most commonly SSRI or SNRI and benzodiazepines are given. Benzodiazepines are 
usually the first line of treatment, as acute relief of symptoms occurs, but for longer term 
treatment tolerance and dependence occurs so SSRI and SNRI are drugs of choice.   
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5. Pain disorder 
  Ascending cortical pathways involving monoamines, responsible for some role in 
analgesia. Antidepressants have analgesic property in addition. Given in chronic pain 
associated with depression.Antidepressants are not given in normal routine as painful, non-
responding debilitating pain known as neuropathic pain of DM, post hepatic neuralgic pain, 
trigeminal neuralgia, chronic backache. Most commonly TCAs and SNRI are used. 
Duloxetine is well known for this condition. 
6. Premenstrual dysphoric disorders  
 Becomes irritable and change in mood occurs, which is usually mild. In some, 
troublesome signs, symptoms appear like fatigue, irritability, depression, seen in 2nd half of 
menstrual cycle (luteal phase), related somewhat to increased levels of progesterone.  
  SSRI – Fluoxetine has been used successfully, used either continuously or for these 
two weeks of luteal phase. Both ways equally effective. 
7. Smoking cessation:  Bupropion, has different mechanisms: 
 Nicotine like action, norepinephrine, dopamine 
 Antagonistic effect on nicotinic receptors. 
 Nicotine has antidepressant property, substitute for nicotine. As effective as 
transdermal nicotine patch. Other drug is nortiptyaline.  
8. Miscellaneous 
 Enuresis –children night bed wetting TCA are given, Impaprazine, advantage is that 
also has anticholinergic property. Bladder control is improved. It has less sedating 
effects, child wakes up easily. 
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 For urinary stress and incontinence duloxetine is prescribed 
 Vasomotor symptoms –premenopausal, menopausal if troublesome, antidepressants 
can be given SNRI Venlafaxine, nefazadone. As SSRI delay sexual functions, they 
are given in certain sexual dysfunctions like premature ejaculation. Chronic use 
depends on patient‟s profile, age, gender, and existing diseases. Also on drug 
tolerability and toxicity profile.  
Specific clinical uses 
SSRI    :  Depression, Anxiety disorder, Bulimia nevosa 
5HT2 antagonist  :  Depression, Anxiety disorder,Insomnia 
Tetracyclic and unicyclic  
antidepressants  :  Depression unresponsive, Buproprion –obesity 
SNRI   :  Depression, Pain disorder, Anxiety disorder, Stress,                   
       Urinary     incontinence, 
TCAs    :  Depression unresponsive, Pain disorder, Enuresis,  
     Insomnia 
MAOs    :  Anxiety disorder, Selegiline –parkinson‟s disorder[20] 
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2.  REVIEW OF LITERATURE 
Phytochemical review of  Amaranthus viridis.L 
 Sowjnya pulipati et al., (2014) studied, Phytochemical and Pharmacological of 
Amaranthus viridis.L above presented information regarding Amaranthus viridis (L) 
is reviewed to congregate the ethno-botanical, phytochemical and pharmacological 
information. The plant was reported for various pharmacological activities, hence it 
has broad spectrum of activities in the treatment of numerous ailments. It was 
reported for the presence of few phytoconstituents responsible for few biological 
activities. Hence it is required to isolate the other phytoconstituents which can be 
used as lead molecules in synthesizing novel agents with good therapeutic activity. 
The isolation and characterization of phytoconstituents, elucidation of mechanism of 
action of isolated compounds and clinical trials of compounds are much needed. 
[25] 
  Savithramma N et al., (2012) have reported Preliminary Phytochemical Analysis of 
Traditionally used medicinal Plants. The medicinal plants appear to rich in secondary 
metabolite, widely used in traditional medicine to combat and cure various ailments. 
The anti-inflammatory, antispasmodic, analgesic and diuretic can be attributed to 
their high phenols, tannins, triterpenoids, saponins, flavonoids. Exploitation of these 
pharmacological properties involves further investigation active ingredients by 
implementation of technique like extraction, purification, separation, crystallization 
and identification.
[26] 
 Oliva c. Ruma., (2016) have been reported phytochemical screening of selected 
indigenous edible plants, In this study, although there are variations in the chemical 
constituents found to be present, the result gave comparative information about 
the main classes of secondary metabolites found in the indigenous edible plants 
evaluated. Therefore, the current findings revealed the richness of the indigenous 
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edible plants in different groups of active compounds that need to be studied for 
different applications may help achieve nutritional security.[27] 
 Barnali Gogoi et al., (2013) have been reported Phytochemical Constituents of Some 
Medicinal Plant Species Used in Recipe During „Bohag Bihu‟ in Assam. An ethno 
botanical study has been carried out to focus on medicinal utility of 101 plant species 
eaten during Bohag Bihu in Assamese society. Amongst 101 species, 25 species are 
found to have effect on gastrointestinal problem, 18 species effect on skin diseases, 
16 species effect on respiratory ailments, 14 species effect as anti diabetic, 7 species 
effect on gynaecological problems, 6 species effect as blood purifier, 4 species effect 
on rheumatism, 3 species effect on eye-sight improvement and 2 species effect on 
jaundice. These plants contain various phytochemicals like saponins, alkaloids, 
sterols, flavanoids, glycosides, terpenoids which have certain medicinal values. The 
paper reflects the rich ethno medicinal value of the herbs along with their 
phytochemical constituents The further scrutiny  evaluation of the safety parameters 
of each component of the herb used in the recipe may be investigate to develop a 
pharmacologically potent lead molecule.
[28]
 
 Sehrish sadia et al., (2016) qualitative and quantitative phytochemical analysis and 
antioxidant potential of Amaranthus viridis.L by using different assays. The results of 
present study showed that extract of A. viridis leaves contain high amount of 
flavonoides and phenolic contents and exhibited high antioxidant activity. Previous 
documentations showed that high scavenging activity is related to the presence of 
hydroxyl group in phenolic compounds structure. As free radicals are highly involved 
in the pathogenesis of a lot of diseases so free radical scavengers can be a preventive 
measure for those diseases. Thus observed radical scavenging activity of A. viridis 
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leaf extract can be exploited for disease prevention as well as nutraceutical 
application.
[29]
 
 Saud Asif Ahmed et al., (2013) Phytochemical Profiling with Antioxidant and 
Antimicrobial Screening of Amaranthus viridis L. Leaf and Seed Extracts. From the 
study it was concluded that the edible plant species Amaranthus viridis from 
underutilized plant family had a rich amount of valuable ingredients that are 
beneficial for health[30] 
 Liu D et al,. Studied the effects of different concentration (10(-6)M. 10(-5)M and 
10(-4)M ) of K2CR2O7CR(VI) on some minerals (Mn, Fe, Cu and Zn), Lipid 
peroxidation, activaties of antioxidants enzymes, Photosynthetic function, and 
chlorophyll  fluorescence characteristics were investigated in hydroponically grown 
Amaranthus viridis L. Results indicated that chromium was accumulated primarily in 
roots[31] 
 Larbie Christopher et al., (2015) studied the effect of phytochemical and phenolic 
content, anti oxidant and anti proliferative effects of 50% ethanolic extract of 
Amaranthus viridis L. Leaves and stem using standard methods.Amaranthus viridis L. 
MTT assay, it was observed that all the extract had anti-proliferative activity against 
3 leukemic cell lines (Jurkat, CEM and HL -60). The AVL had IC50 value of 
111.41µg/ml (JURKAT), 122.5µg/ml (HL-60) and >1000 (CEM). It was also observed 
extract enhanced the proliferation of normal cells while the standard curcumin had 
an anti-proliferative effect on leukemic and normal cells. It can be concluded that 
the better anti oxidant and pro-liferative effect and could furher be explored as a 
novel source of cancer therapy.[32] 
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 L. Prabhas et al., (2016) studied preliminary phytochemical analysis of some 
traditional medicinal plants, Qualitative phytochemical analysis of selected plant 
species confirms the presence of various phytochemicals like alkaloids, flavonoids, 
steroids and terpenoid. The presence of phytochemicals can be unified with 
medicinal potential of these plants. Research study reveals the scientific evidences 
associated with use of traditional medicinal plants for the treatment of various 
diseases among human beings.[33] 
 Jana Kalinova et al., (2009) studies were conducted to confirm the presence of 
rutin, one of the most common quercetin glycosides, and other quercetin 
derivatives in plants of genus Amranthus[34] 
Pharmacognostical review of  Amaranthus viridis. L 
 Musharaf khan et al., (2010) studied the Pharmacogonostic evaluation of the 
Amanaranthus viridis L. (Family Amaranthaceae) plant was studied to determine the 
various parameters for pharmacognostical standards. The present investigation deals 
with the report on macro and microscopical, vein islet and vein termination numbers, 
palisade ratio, stomatal index (upper and lower surfaces of the leaf) and different 
chemical parameters have been determined. These findings will be useful towards 
establishing pharmacognostic standards on identification, purity, quality and 
classification of the plant, which is gaining relevance in plant drug research.
[35]
 
Pharmacological review of Amaranthus viridis.L 
 B.S.Ashok Kumar et al., (2010) showed the invitro anthelmintic property of 
methanol extract of Amaranthus viridis Linn, Antinociceptive and antipyretic 
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Activities and (2009) estimation of Bioflavonoid in Amaranthus viridis Linn by 
HPLC
[36]
 
 Girija K et al., (2011) to investigate the Methanol extract of Amaranthus viridis.L 
,Amaranthus caudatus.L,Amaranthus spinosus.L, showed significant anti-diabetic 
and anti-cholestrolemic activity, which proves the scientific proof for their 
traditional claims.
[37]
 
 Vrushali jadhav et al., (2016) studied Evaluation of antioxidant activity of 
Amaranthus viridis.L Methanolic extract, in this study, we prepared and evaluated 
antioxidant activity of selected plant extracts. This result showed that tested plant 
products had noticeably antioxidant effect and total phenolic content. Antioxidant 
compounds from these products with preventive and treatment effect on various 
diseases can be used for improving the shelf life of food products. The present study 
may help in use of these naturally occurring species in the  development of new 
drug
[38]
 
 Kausar malik et al., (2016) have been reported the Anti bacterial activity of 
Amaranthus viridis L. In his study, Samples of medicinal plants were extracted using 
water and methanol and tested for their antimicrobial activities against pathogenic 
stains and usual strains of wound causing bacteria by disc diffusion method. 
Methanol extracts had comparatively more activities as compared to their 
corresponding aqueous extracts. Polarity of methanol and high stability of plant 
secondary metabolite in methanol could be probable reason for high extractive value. 
Chloroform extracts of A. viridis were found to show lesser inhibition than methanol 
and ethanol. This was supported by statistical analysis for both stem and leaves. This 
finding was reported by Islam et al [39] 
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 Sivaji Asha et al., (2013) have been reported  the Antiurolithiatic Activity of 
Amaranthus viridis.L, In this studied ,the data revealed were suggested that 
Amaranthus viridis.L possess significant antiurolithiatic activity
[40]
 
 Ying-Shan Jin et al., (2013) have been reported the Anticancer activities of extract 
from Amaranthus viridis.L, Study of demonstrated that ethyl ether fraction of 
A.viridis.L (EA) has an anti-proliferative effect by reducing cell viability, ROS 
generation, regulation of the caspase-3 gene, activation o Bax and Bcl-2 and cell 
cycle arrest. EA increases the level of ROS and apoptotic cell death in HT-29 cancer 
cells. Our results demonstrate that the cell apoptosis induced by EA induces G0/G1 
cell cycle arrest and was associated with generation of ROS  and enhanced 
expression of capase-3 and Bax/Bcl-2 ratio.
[41]
 
 Ashok Kumar BS et al., (2011) have been reported the Hepatoprotctive and 
antioxidant activities of Amaranthus viridis.L, In conclusion, administration of 
MeAv for liver protective activity against paracetamol induced liver damage the 
potential antioxidant property of MeAv  thought to be the mechanism behind its 
hepatoproctive activity.
[42]
 
 Adewale Adetutu et al., (2016) studied in Inhibition of vivo growth plasmodium 
berghei by launaea taraxacifolia and Amaranthus viridis.L in mice.The results of 
this study can be used as basis for further phytochemical investigation in the search 
for new and locally affordable antimalarial agents.
[43]
 
 Saikia et al., (2015) study was to determine the anticonvulsants activity of 
methanolic extract of Lawsonia inermis leaves in albino rats. The anti convulsant 
activity of methanolic extract of leaves of lawsonia inermis (200mg/kg and 
400mg/kg)  was assessed in rats using maximum electroshock seizure (MES) test ant 
pentylenetetrazole(PTZ) induces seizure test. The study demonstrate that Lawsonia 
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inermis has significant anticonvulsant activity possibly through a GABA-ergic 
interaction.
[44]
 
 O.O. Adeyemi et al., (2010) studied investigate the anticonvulsant, anxiolytic and 
sedative activities of the aqueous root extract of Securidaca longepedunculata, 
These findings justify the use of Securidaca longepedunculata in traditional 
medicine for the management of convulsion and psychosis.
[45]
 
 Jiban Debnath et al., (2010) have been reported the anticonvulsant activity of 
ethanolic extract of Terminalia chebula in albino mice. Ethanolic extract of 
Terminalia chebula (EETC) possess anticonvulsant activity since it reduced the 
duration of seizures produced by maximal electroshock and delayed the latency of 
seizures produced by pentylenetetrazole and picrotoxin.
[46]
 
 Nadithe Laxman Reddy et al., (2016) have been reported demonstrated that Citrus 
sinensis possesses anticonvulsant activity against Maximal Electric Shock induced 
seizures in mice. The anticonvulsant activity was better with dose of 100mg/Kg as 
compared to 50mg/Kg. However its anticonvulsant properties were inferior to the 
standard drug Sodium valproate. It may only act as an adjuvant therapy along with 
standard anticonvulsant drugs in seizure prevention.
[47]
 
 Saba hasan et al., (2012) have been reported Anti epileptic activity of some 
medicinal plants. These remedies can make anti convulsant treatment more rationale 
and patient friendly. In conclusion, the medicinally important plant species, listed in 
the present paper appear to be promissory sources of anticonvulsant agents. The 
future outlook for the development of new antiepileptic drugs derived from these 
medicinal plants is therefore positive.
[48]
 
 Jhansi Konduru et al., (2014) studied, Even though the antidepressant drugs can 
treat the disorders like depression, but they have side effects too. Upon doctor‟s 
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suggestion only it is better to use within the limit and also use the appropriate drug in 
order to reduce the symptoms.
[49]
 
 Ramiro Salas et al., (2003) have reported Altered Anxiety-Related Responses in 
Mutant Mice Lacking the _4 Subunit of the Nicotinic Receptor. we showed that the 
lack of the nAChR _4 subunit alters the behavioral responses to certain anxiety-
provoking experimental paradigms. The effect might be dependent on the MHb–IPN 
expression of the _4 subunit. The data on _4, _3, and_4 co expression might help to 
explain how different nAChR types can exert their influence on anxiety-related 
behavioral tests.
[50]
 
 Angelika Roedel et al., studied Effects on light or dark phase testing on behavioural 
and cognitive performance in DBA mice. From the results we conclude that testing 
during the light phase induces a pronounced behavioural inhibition as well as a 
cognitive disruption in DBA mice, which should be taken into account when 
cognitively testing these animals.
[51]
 
 John Michael Holden et al., (2015) have been reportd Behavioral effects of 
mefloquine in tail suspension and light/dark tests. study concludes that acute 
administration of mefloquine leads to some behaviors indicative of emotional 
disinhibition in mice, including increased rearing and time in light in the light/dark 
apparatus and reduced immobility in the tail suspension test.
[52]
 
 Michel Bourin et al., (2003) have been reported to be an index of activity-
exploration because of habituation over time, and the time spent in each 
compartment to be a reflection of aversion. Classic anxiolytics (benzodiazepines) as 
well as the newer anxiolytic-like compounds (e.g. serotonergic drugs or drugs acting 
on neuropeptide receptors) can be detected using this paradigm. It has the 
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advantages of being quick and easy to use, without requiring the prior training of 
animals.
[53]
 
 Vinod H. Gupta et al., (2012) have been reported Neuropharmacological 
Evaluation of the Methanolic Extract of Couroupita guianensis Aubl. Flower in 
Mice. Appears that the methanolic extract of C. guianensis can cause a central 
nervous system depression indicates active sedative properties which may be the 
basis of its folkloric use in traditional medicine to reduce pain. However our results 
need to be further corroborated with different models to speculate on the mechanism 
of action.
[54]
 
 Digambar B. Ambika et al., (2014) have been reported Evaluation of 
neuropharmacological activity of petroleum ether, Methanolic and aqueous extracts 
of flower heads of Sphaeranthus Indicus in mice SIP and SIM demonstrated 
significant anxiolytic and anticonvulsant activity. SIM and SIA showed 
improvement in discrimination index. More over SIM showed anti-hypoxic activity 
and delayed sodium nitrate induced respiratory arrest.
[55]
 
 Moli Akter et al., (2011) have been reported Evaluation of analgesic, 
neuropharmacological and cytotoxic activity of Trigonella foenum-graecum Linn. 
Phytochemical screening of the extract showed that the Trigonella foenum-graecum 
possess fibers, flavonoids, polysaccharides, saponins, flavonoids and 
polysaccharides fixed oils and some identified alkaloids viz., trigonelline and 
choline. The analgesic, CNS depressant and cytotoxic properties of Trigonella 
foenum-graecum observed in animal model might, in part, be due to the presence of 
such compounds. The results also suggest a rationale for the traditional uses of this 
plant. However, studies are required on higher animal model and subsequently on 
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human subjects to prove its clinical efficacy as an analgesic, CNS depressant and 
cytotoxic agent.
[56]
 
 Mohammad Shahriar et al., (2014) have been reported analgesic and 
neuropharmacological activity of withania somnifera root, After pharmacological 
studies with root extracts of Withania somnifera for analgesic activity and 
neuropharmacological investigation, plant root has significant analgesic activity and 
neuropharmacological action.[57] 
  Yogesh Chand Yadav et al., (2013) have been reported Neuropharmacological 
screening techniques for pharmaceuticals. This screening model can be use to study 
of memory enhancing, Anxiolytic, Antidepressant and anticonvulsant activity.[58] 
Ethno botanical Information of Amaranthus viridis.L 
 Leaf sap is used as an eye wash treat eye infections, convulsions and epilepsy in 
children: powder leaf contains reducing sugars and resins that have allolipathic 
effects on lettuce seed germination, A Review of Nutritional value and utilization of 
Amaranthus (AMARANTHUS SPP).[59] 
 Leaves is orally administered for fistula and piles, ethnomedical survey was carried 
out in the five villages of Narsinghdi district, Bangladesh.
[60]
 
 Leaves are having the Antimicrobial, antioxidant, laxative, anti-inflammatory, skin 
infection etc. (2016) 2nd international conference on recent innovation technology, 
management and enviorement.[61] 
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3.  PLANT PROFILE 
 
 
Fig-8 :Plant  of Amaranthus viridis Linn 
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GENERAL INFORMATION: 
Common name       - Green Amaranth, pigweed, Prince of Wales feather, slender 
amaranth, Tropical green amaranth 
Synonym - Amaranthus gracilis, Amaranthus polystachyus, Euxolus viridis 
Family - Amaranthaceae 
 
TAXONOMICAL CLASSIFICATION: 
Kingdom - Plantae - plants 
Subkingdom - Tracheobionta – Vascular plants 
Family - Amaranthaceae 
Superdivision - Spermatophyta – seed plants 
Division - Magnoliophyta – Flowering plants 
Class - Magnoliophyta – Dicotyledons 
Subclass - Caryophyliidae 
Order - Caryophyllales 
Family - Amaranthaceae – Amaranth family 
Genus - Amaranthus L. – pigweed 
Species  Amaranthus polygonoides L. – Tropical amaranth 
 
                -          
 
 
VERNACULAR NAME: 
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Tamil - Kuppaikeerai 
Malayalam - kuppacheera 
Hindi   - Jungali chaulayl 
Telugu   - Chilaka – thotakoora 
Marathi   - Unadabhaji 
Sanskrit - Tandulya
[62]
 
                          
BOTANICAL DESCRIPTION 
A.viridis is an annual herb with an upright, light green stem that grows to about 60-80 
cm in height. Numerous branches emerge from the base, and the leaves are ovate, 3-6 cm 
long and 2-4 cm wide, long petioles of about 5 cm. The plant has terminal panicles with few 
branches, and small green flowers. 
ECOLOGY 
 It requires well drained fertile soil in a sunny position. It should not be provided with 
inorganic fertilizer. It is cultivated as a food in tropical countries. It photosynthesis by C4 
carbon-fixation pathway which effects at high temperature.  
PROPAGATION 
A.viridis is propagated by sowing seeds in spring. Germination is rapid if the soil is 
warm. A drop in temperature overnight will assist the germination. Apart from seeds the 
cuttings of growing plants are also used for propagation which roots easily. 
 
USES  
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 The herb is used as astringent, emollient, in dysentery, inflammation, constipation,                     
eczema, bronchitis, antidiabetic, anaemia and leprosy, Plant is used as sag for cooking 
and fodder plant.  
 Leaves are emollient and anthelmintic. Roots/ shoots are used to control excessive 
menstruation, blood purifier, digesting agent, piles.  
 The Negros of the Philippines apply the bruised leaves directly to eczema, psoriasis, 
and rashes with good results.  
 The leaves make a good emollient preparation available in some of the Filipino 
villages for insect bites, sunburn, and regular burns.  
 The reddish-brown fiber from the leaves are soaked and use for eye treatments.  
 The decoction of young roots is used for the treatment of respiratory complaints, 
asthma.  
 Provides energy: Highly packed with carbohydrates, proteins, vitamin K, folate, 
riboflavin, vitamin A, vitaminB6, and vitamin C, amaranth leaves boost energy in the 
body.  
 Prevents electrolyte imbalance: Amaranth leaves are terrific source of manganese, 
iron, copper, calcium, magnesium, potassium and phosphorus necessary for 
maintaining proper mineral balance in the body.   
  Improves digestion: High dietary fiber content (3 times that of wheat) in the greens 
improve digestive health and reduces constipation. It is easily digestible and good for 
both young ones and elders.  
  Aids in weight management: Protein in the leaves help to reduce insulin levels in the 
blood and also release a hormone that lessen hunger pranks and prevent "binging 
catastrophe".  
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 Reduces bad cholesterol: One of the key benefits of amaranth leaves is cholesterol-
lowering ability. Being fibrous, this leafy vegetable is effective in reducing LDL 
levels in the blood and promotes weight loss. Presence of tocotrienols (a type of 
vitamin E) also aids in cholesterol-lowering activity.  
 Good for anemic patients: Iron-rich (5 times that of wheat) red amaranth leaves 
promote coagulation and increase hemoglobin content and red blood cell counts.  
  Decreases risk of cardiovascular disease: Amaranth leaves are an excellent dietary 
source of phytosterols that lowers blood pressure and prevents heart ailments 
including stroke.  
  Fight-off cancer: Presence of lysine (an essential amino acid) along with vitamin E, 
iron, magnesium, phosphorus and potassium and vitamin C helps to fight against free 
radicals responsible for aging and formation of malignant cells.  
  Ayurvedic treatments: Juice extracted from fresh amaranth leaves are prescribed for 
treating diarrhea, and hemorrhage conditions.  
  Stop hair loss and graying: Besides regular consumption, applying juice from the 
leaves prevent brittle hair falling. This wonderful cosmetic benefit of amaranth leaves 
also retards the onset of premature graying.  
  Prevents calcium-deficiency ailments: Calcium present in amaranth leaves reduce 
risk of osteoporosis and other calcium deficiencies because it has twice the calcium 
as milk. Indeed good news for lactose-intolerance.  
  Improves eyesight: Vitamin C found in the leaves contribute to towards healthy 
vision.  
 Green amaranth also has clusters of nutty edible seeds, which can be eaten as snacks 
or used in biscuits. A porridge can be made by boiling the seeds in water. Unlike 
other amaranths, the seeds can be easily harvested by scraping the ripe spikes of 
seeds between the fingers.  
[63]H6  
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4. AIM AND OBJECTIVE 
AIM 
Now-a-days, there is an increase in demand for herbal drugs due to its safety, efficacy 
and better therapeutic results and also due to its economic pricing as compared to allopathic 
drugs. Literature survey has revealed that the plant Amaranthus viridis.L is prescribed in the 
treatment of diabetes, anti-cholesterolemic, anti-pyretic and anti-nociceptive, 
hepatoprotective, anti oxidant conditions etc The plant, Amaranthus viridis.L was selected 
for the present study its, 
a) Easy availability 
b) Good therapeutic activity 
c) Degree of research work which is not done 
Very less pharmacological studies have been carried out on the plant Amaranthus 
viridis.L. As per the literature review, so far no scientific study has been carried on this plant 
Amaranthus viridis.L (Family: Amaranthaceae) to explore the neuroprotective activity. So, 
the present study has been under taken to explore the neuropharmacological effect of leaves 
of methanolic extract of leaves of Amaranthus viridis.L which includes studies on 
pharmacological, Preliminary phytochemical and its pharmacological evaluation. 
OBJECTIVES 
a) To determine the phytochemical constituents present in the methanolic extract of 
leaves of A.viridis L., 
b) To investigate methanol extracts of leaves of Amaranthus viridis .L (Amaranthaceae) 
for various neuropharmacological activities, such as anti convulsant, anti depressant 
and anxiolytic 
.
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5.  PLAN OF WORK 
The present investigation was focused on the following: 
 Collection of  plant 
 Authentication of the plant 
 Extraction of plant material with methanol 
 Pharmacognostical studies 
A. Transverse section of leaves 
B. Analytical Parameters 
a) Ash value 
b) Extractive value 
c) Loss on drying 
 To carry out the  preliminary phytochemical screening of the extract 
 To carry out the pharmacological screening of the methanolic extract of Leaves of 
Amaranthus virdis.L for, 
 ANTI – CONVULSANT ACTIVITY 
a) Maximal electroshock –induced convulsion (MES) 
 ANTI – DEPRESSANT ACTIVITY 
a) Forced swimming test (FST) 
b) Tail suspension test (TST) 
 ANTI - ANXIETY ACTIVITY 
a) Elevated plus maze test (EPM) 
b) Light- dark Test (LDT) 
 Statistical Analysis 
 Documentation of results 
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6. MATERIALS AND METHODS 
Collection, identification and authentication of plant material: 
The plant of Amaranthus viridis.Linn was collected in the month of January, 2017 
from the house garden, Nasiyanur, Erode district, Tamil nadu, India. The plant material was 
identified and authenticated by Dr. A. Balasubramaniam, Research Consultant, ABS 
Botanical garden, Kaaripatti, Salem District, Tamil nadu. 
Shade drying, Granulation and Extraction: 
The plant leaf were taken and dried in shade. Then the shade dried leaf were coarsely 
powdered by means mix grinder and was through sieve no 60 to get the coarse powder. Then 
the coarsely powdered materials were weighed, packed in an airtight container and used for 
extraction with solvent, phytochemical studies and pharmacological studies.  
METHOD OF EXTRACTION 
Soxhlet extraction: 
Soxhlet extraction is the process of continuous extraction in which the same solvent 
can be circulated through the extractor for several times. This process involves in the 
extraction followed by evaporation of the solvent. The vapours of the solvent are taken to a 
condenser and the condensed liquid is returned to the drug for continuous extraction.  Soxhlet 
apparatus designed for such continuous extraction consists of a body of extractor attached 
with a side tube and siphon tube. The lower of the extractor is attached to distillation flask 
and the mouth of extractor is fixed to a condenser by the standard joints. The powdered crude 
drug is packed in the soxhlet apparatus directly or in a thimble of filter paper or fine muslin 
cloth. The diameter of the thimble corresponds to the internal diameter of the soxhlet 
extractor. Extraction assembly is set up by fixing condenser and a distillation flask. Initially 
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for the setting of the powder, solvent is allowed to once before heating. Fresh activated 
porcelain pieces are added to the flask to avoid bumping of the solvent. The vapours pass 
through the side tube and the condensed liquid gradually increase the level of liquid in the 
extractor and in the siphon tube. A siphon is set up as the liquid reaches the point of return 
and the contents of the extraction chamber are transferred to the flask. The cycle of solvent 
evaporation and siphoning back can be continued as, many times as possible changing the 
solvent, so as to get efficient extraction. This method although a continuous extraction 
process, is nothing but a series of short macerations.
 [64] 
Preparation of plant extract: 
About 350 gm of coarsely powdered leaf was packed in 1000ml soxhlet apparatus and 
extract with methanol for 72 hours by continuous hot percolation. After extraction, the 
solvent was distilled off and extract was concentrated to at room temperature and the 
percentage yield was calculated. 
PHARMACOGNOSTICAL STUDIES  
Tranferse section of leaves of (T.S) Amaranthus viridis.L 
 T.S of petiole, T.S of midrib, T.S of lamina, venation pattern was done and its 
procedure was given below as follow. 
Fixation 
Care was undertaken to select healthy plant and normal organs. The required sample 
of different was cut and removes from the plant and fixed in FAA (Formalin -5ml+ acetic 
acid 5ml+70% ethyl alcohol 90ml). After 24 hour of fixing the specimen were dehydrated 
with graded series of tertiary butyl alcohol. 
[65]
 Infiltration of specimen was carried out by 
gradual addition of paraffin wax (melting point 58-60ºC) until TBA solution attained super 
saturation. The specimens were cast into paraffin blocks. 
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Sectioning:  
The paraffin embedded specimens were sectioned with the hand and dewaxing of 
section was customary procedure. 
[66]
 The sections were stained with toludine blue. Since 
toludine blue is polychromatic stain. The staining results were remarkable good and some 
cytochemical reactions were also obtained. The dye rendered pink colour to the cellulose 
wall, blue to the lignified cells, dark green to suberin, violet to mucilage, blue to protein 
bodies etc. Where ever necessary sectioned were also stain with safranin and IKI (for starch) 
[67] 
For studying the stomatal morphology, venation pattern and trichome distribution, 
Para dermal section (section taken parallel to the surface of leaf) as well as clearing of leaf 
with the 5% sodium hydroxide or epidermal peeling by partial maceration employing 
Jeffery‟s maceration fluid were prepared. Glycerin mounted temporary preparation were 
made for macerated /cleared materials. Powdered materials of different parts were cleared 
with sodium hydroxide and mounted in glycerin medium after staining. Different cell 
component were studied and measured. 
Photomicrograph: 
Microscopic descriptions of tissues are supplement with micrographs where ever 
necessary. Photograph of different magnification were taken in Nikon labphoto 2 microscope 
units. For normal observations bright field was used. For the study of crystal, starch grains 
and lignified cells, polarized light was employed. Since these structures have birefringent 
property, under the polarized light they appear bright against dark back ground. 
Magnifications of the figure are indicated by the scale bars
 [68]
. 
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ANALYTICAL PARAMETERS 
 Ash values, extractive value, loss on drying were used for the study of physical 
properties. 
Ash value 
Ash values are helpful in determining the quality and purity of crude drug, especially 
in the powdered form. The ash of any organic material is composed of their non-volatile 
inorganic components. Controlled incineration of crude drugs results in an ash residue 
consisting of an inorganic material (metallic salt and silica). This value varies within fairly 
wide limits and is therefore, an important parameter for purpose of evaluation of crude drugs. 
In certain drugs, the percentage variation of the weight of ash from sample to sample is very 
small and any marked difference indicates a change in quality. The ash value can be 
determined three different methods to measure the total ash, the acid insoluble ash and water 
soluble ash. 
Determination of total ash value 
Weigh accurately about 5gm of air dried powdered drug was taken in a tarred silica 
crucible and incinerated by gradually increasing the temperature to make it dull red until free 
from carbon cooled weighed then calculated the percentage of total ash with reference to air 
dried drug.
 
Determination in of acid insoluble ash value 
Boil the total ash with 25ml of 2M Hcl for 5 minute, collect the insoluble matter in a 
gooch crucible or on an ash less filter paper and wash hot water, ignite then  cool in a 
desiccators and weight. Calculate the percentage of acid insoluble ash with reference to the 
air dried drug. 
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Determination of water soluble ash value 
Water soluble ash is that part of the total ash content which is soluble in water. It is 
good indicator of either previous extraction of the water soluble salts in the drugs of incorrect 
preparation. 
To the crucible containing the total ash, add 25ml of water and boil for 5 minutes. 
Collect the insoluble matter in a sintered glass crucible or on an ashless filter paper. Wash 
with hot water and ignite in a crucible for 15 minutes at a temperature not exceeding 450
o 
c. 
Substract the weight residue in mg from the weight of total ash. Calculate the content of 
water soluble ash in mg/g of the air dried material. 
Determination of sulphated ash value 
Heat silica of platinum crucible to redness for 10 minutes; allow cooling in 
desiccators and weighing. Unless otherwise specified in the individual monograph, transfer to 
the crucible 1 gm of the substance under examination and weigh the crucible and the contents 
accurately. Ignite, gently at first, until the substance is thoroughly charred. Cool, moisten the 
residue with 1 ml of H2SO4 heat gently until the white fumes are no longer evolved and ignite 
at 800
o
± 25
o
C until all black particles have disappeared. Conducted the ignition in a place 
protected from air current. 
EXTRACTIVE VALUES 
This method is to determine the amount of active constituents in a given amount of 
medicinal plant material when extracted with solvent. It is employed for that material for 
which no chemical or biological assay. 
Determination of alcohol soluble extractive value 
5gm of air dried and coarsely powdered drug has to be macerated with 100ml of 
ethanol of the specified strength in a closed flask for 24 hours, shaking frequently during the 
first 6 hours and allowed to stand for 18 hours. Thereafter, filter rapidly taking precautions 
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against loss of ethanol. Evaporate 25 ml of filtrate to dryness in a tarred flat-bottomed 
shallow dish, dry at 105
o
c and weigh. The percentage of ethanol soluble extractive value with 
reference to the air dried drug has to be calculated. 
Determination of water soluble extractive value 
The water soluble extractive value plays an important role for the evaluation of crude 
drugs. 5gm of the air dried and coarsely powdered drug as to be macerated with 100 ml of 
water of the specified strength in a closed flask for 24 hours, shaking frequently during the 
first 6 hours and allowing for 18 hours. Thereafter, filter rapidly taking precautions against 
loss of water. Evaporate 25 ml of filtrate to dryness in a tarred flat-bottomed shallow dish, 
dry at 105
o
c and weigh. The percentage of water soluble extractive value with reference to 
the air dried drug has to be calculated. 
LOSS ON DRYING 
Loss on drying is the loss of mass expressed as percentage w/w. It determines both 
water and volatile matter in the crude drug. It can be carried out either by heating at 100-105
o 
c or in desiccators over phosphorus pent oxide under atmospheric or reduced pressure at 
room temperature for specified period of time. 
Procedure 
About 2 gm of powdered drug was taken in a tarred porcelain dish which was 
previously dried at 105
o
c in hot air oven to constant weight and then weighed. Percentage of 
loss drying with reference to the air dried substance was calculated.
 [69][70] 
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PRELIMINARY PHYTOCHEMICAL ANALYSIS 
1. TEST FOR CARBOHYDRATES 
A small quantity of the extract was dissolved separately in 4 ml of distilled water and 
filtered. The filtrate was subjected to be following tests to detect the absence of 
carbohydrates and glycosides. 
a) Molich’s test: 
The filtrate was treated with 2-3 drops of 1% alcoholic α-naphthol solution and 2 ml 
of concentrated sulphuric acid was added along the test tube. Dis-Appearance of 
brown ring at the junction of two liquids shows presence of carbohydrates. 
b) Fehling’s test: 
The filtrate was treated with 1 ml of Fehling‟s solution A and B and heated on the 
water bath. A reddish precipitate was obtained shows the  carbohydrate. 
c) Test for pentose sugar: 
Mix equal amount of test solution and HCL. Heated and added the crystal of 
phloroglucinol. Presence of carbohydrates. 
2. TEST FOR FIXED OIL AND FATS 
a) Spot test: 
Small quantity of the extract was pressed two filter paper, No appearance of oil stain 
on the paper indicates the absence of fixed oil. 
b) Saponification Test: 
Add a few drops of 0.5N alcoholic potassium hydroxide to a small quantity of various 
extracts along with a drop of phenolphthalein separately and heat on a water bath for 
1-2 hrs. No changes occur indicates the absence of oil and fats. 
c) Treat 5 drops of sample with 1% sulphate solution, and then add 10% sodium 
hydroxide solution. A clear blue solution is obtained which shows glycerine is present 
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in the sample. The cupric hydroxide formed in the reaction does not precipitated out 
as it solution in glycerine.  
3. TEST OF PROTEINS 
a) Biuret Test: 
To the extract solution (2 ml) and biuret reagents was added, Violet colour indicates 
the presence of protein. 
b) Xanthoprotein Test: 
To 5 ml of extract solution, 1 ml of nitric acid was boiled, yellow precipitate was 
formed. After cooling it, add 40% sodium hydroxide solution orange colour was 
formed. 
c) Millions Test: 
2 ml of the test solution was mixed with millions reagent, white precipitate was 
formed. 
4. TEST FOR STROIDS 
a) Salkowski’s Test: 
To 1 ml of chloroform solution, few drops of concentrated sulphuric acid were added. 
Brown colour produced showing the presence phytostrols. 
b) Libermann – berchard’s Test: 
The extract was added with few drops of acetic anhydride. Boiled and cooled. Then 
concentrated sulphuric acid was added from the side of the test tube, brown ring was 
formed at the junction of two layers and upper layer turned green which showed 
presence of steroids. 
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5. TEST FOR GLYCODIDES 
 TEST 
a) Test A: 
200 mg of the drug was extracted with 5ml of dilute H2SO4 by warming on a water 
bath. It was filtered anf then the acid extracted was neutralized with 5% solution of 
sodium hydroxide. 0.1 ml of fehling‟s solution A and B added until it became alkaline 
and heated on a water bath for 2 minutes , the quantity ofred precipitate formed was 
noted and compared with that of formed in test B. 
b) Test B: 
200gm of drug was extracted with 5 ml of water instead of H2SO4 .After boiled equal 
amount of water was added. 0.1 ml of fehling‟s solution A and B was added until it 
becomes alkaline and heated on a water bath for 2 minutes. The quantity of red 
precipitate formed was noted. The quantity of precipitate formed in test B with that 
formed in test A was compared. And it shows the presence of glycosides. 
6. TEST FOR CARDIAC GLYCOSIDE 
a) Baljiets Test: 
The extract was mixed with picric acid or sodium picrate. Orange colour was formed. 
Indicates the presence of glycosides. 
b) Legal’s Test: 
To the alcoholic solution of extract, 1 ml pyridine and 1 ml sodium nitro-pruside 
solution, blood red colour was observed shows the presence of cardiac glycosides. 
c) Keller-killiani Test: 
To 2 ml of the extract, 3ml of glacial acetic acid and 1 drop of 5% ferric chloride were 
added. This solution was carefully transferred to the surface of 2ml concentrated 
H2SO4 and the observed was noted down. 
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7. TEST FOR ANTHRAQUINONE GLYCOSIDES 
a) Borntrager Test: 
The test material was boiled with 1 ml H2SO4 in a test tube for five minutes. It was 
filtered while hot, the filtrate was cooled and shaken with equal volume of 
dichlormethane or chloroform. The lower layer of dichloromethane or chloroform was 
separated and shaken it with half of its volume of dilute ammonia. No rose pink to red 
colour was produced in the ammonical layer.  
b) Modifed Borntrager Test: 
200 mg of the material was boiled with 2 ml of dilute H2SO4. I t was treated with 2 ml 
of 5% aqueous ferric chloride solution for 5 minutes. It was shaken with equal volume 
of chloroform. The organic solvent layer were separated and add equal volume of 
dilute ammonia was added, ammonia layer shows pinkish red colour. Shows the 
presence of glycosides. 
8. TEST FOR FLAVONOIDS 
a) Shinoda’a Test: 
To the extract solution few magnesium turning were added and concentrated Hcl was 
added drop wise, pink scarlet, red appeared after few minutes showed its presence of 
flavonoids. 
b) To small quantity of residue lead acetate solution was added & the colour changes 
was observed. 
9. TEST FOR FATS AND OILS 
a) Solubility Test: 
i) To 2-3ml of the extract, few ml of chloroform was added and solubility 
was observed. 
       MATERIALS AND METHODS                                                           
DEPT.OF PHARMACOLOGY, THE ERODE COLLEGE OF PHARMACY & RESEARCH INSTITUTE80 
 
ii) To 2-3ml of the extract few ml of 90% methanol was added and 
solubility was observed 
10. TEST FOR TANNINS AND PHENOLIC COMPOUNDS 
a) Ferric chloride Test: 
To the test solution, ferric chloride solution was added, green colour appeared 
showing the presence of condensed tannins. 
b)  Phenazone test 
To the test solution, 0.5 grams of sodium phosphate was added, warmed and filtered. 
To the filtrate 2% phenazone solution was added, bulky precipitate was formed which 
was often coloured, indicating the presence of tannins. 
11. TEST FOR ALKALOIDS 
The extract is evaporated separately. To the residue dilute HCL was added and it was 
shaken well and filtered. The following tests were performed. 
a) Dragendroff’s Reagents: 
To 2-3ml of filtrate few drops of dragendroff‟s reagents were added and precipitate 
was observed. It indicates the presence the alkaloid. 
b) Mayer’s Test: 
To 2-3ml of filtrate few drops of mayer‟s reagents were added and precipitate was 
observed. It indicates the presence of alkaloids. 
c) Hager’s Test: 
To 2-3 ml of filtrate few drops of hager‟s reagents (saturated solution of picric acid) 
were added and precipitate was observed. It indicates the presence of alkaloids. 
d) Wagner’s Test: 
To 2-3 ml of filtrate few drops of wagner‟s reagents were added and the precipitate 
was observed. It indicates the presence. 
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12. TEST FOR AMINO ACIDS: 
a) Ninhydrin Test: 
3ml of the test solution was heated with 3 drops of 5% ninhydrin solution in a boiling 
water bath for 10 minutes and then the dark blue colour was observed. Shows the 
presence of amino acids. 
b)  Millon’s Test: 
To test solution about 2ml of millon‟s reagents was added. A white precipitate was 
obtained indicating the presence of amino acids. 
[71][72] 
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PHARMACOLOGICAL STUDIES 
ANIMAL STUDIES 
Source and Maintenance of Experimental Animals  
Healthy male and female adult rat & mice, weighing between 20-25 g & 150-250 g 
were obtained from the Animal House of the KMCH College of pharmacy, Coimbatore. The 
animals were housed under standard environmental conditions, with feed and water provided 
ad libitum. Proper handling and using of the animals were in accordance with the guidelines 
and regulations, monitored and approved by the Ethical Committee on Animal use, 
Department of Pharmacology, KMCH College of pharmacy, Coimbatore 
ANIMAL MODEL OF CONVULSION 
Maximal Electro Shock (MES) induced Convulsion 
Principle 
The electroshock assay in mice is used primarily as an indication for compounds 
which are effective in grand mal epilepsy. Tonic hind limb extensions are evoked by electric 
stimuli which are suppressed by anti‐epileptics but also by other centrally active drugs. 
Procedure 
The maximum electrical shock (MES) induced convulsion in animals represented 
grand mal type of epilepsy. These are type of procedures use to studies convulsions and to 
test to anticonvulsant drugs in laboratory animals. In MES convulsions electric shock is 
applied through the corneal electrode, through optic stimulation cortical excitation are 
produced .The MES –convulsion are divided into five phase such as Tonic flexion, Tonic 
extensor, Clonic convulsions, stupor, recovery or death. A substance is known to possess 
anticonvulsant property if it reduces or abolished the extensor phase of MES convulsions. 
This procedure may be used to produce convulsions  in rat . In this method place corneal 
electrodes on the cornea and apply the prescribed current and different stages of conclusions 
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are noted as in previous paragraph. Note the time (sec) spent by the animal in each phase of 
the conclusions. Inject phenytoin (i.p) in rats. Wait for 30 min and subject the animals to 
electro‐convulsions as described. Note the reduction in time or abolition of tonic extensor 
phase of MES convulsions.
 [73] 
Experimental Design 
 Wistar albino rats weighed around 150-250g were used for the study. Rats were 
divided into four groups of 5 animals each, 
Group-1 : Received, normal saline (0.1% solution)   
Group-2 : Received standard drug, Phenytoin (20mg/kg i.p.) 
Group-3 : Received methanol extract of leaves of AV (250mg/kg; p.o. Low dose) 
Group-4 : Received methanol extract of leaves of AV (500mg/kg; p.o. High dose) 
ANIMAL MODELS OF ANTI-DEPRESSANT 
Antidepressant activity was indicated the mood elevating due to various mechanism 
of the antidepressant drugs, such as inhibition of the enzyme of monoamine oxidase, 
inhibition of reuptake bioamines and enhancement of the concentration of 5‐HT e) ct .Later 
on, inhibition of reuptake of bioamines was found to be main mechanism of action to 
dowenregulation of β receptor. Several lines of preclinical and clinical evidence indicates that 
enhancement of 5‐HT mediated neurotransmission might underline the therapeutic effect of 
most of the antidepressant This behavioural effect very similar to that found by other author 
after treating mice with classical antidepressant drugs as IMI
 [74]
 .various models are like, 
Forced swimming Test (FST) 
Principle 
Behavioural despair was proposed as a model to test for antidepressant activity. It was 
suggested that mice or rats forced to swim in a restricted space from which they cannot 
escape are induced to a characteristic behaviour of immobility. This behaviour reflects a state 
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of despair which can reduce by several agents which are therapeutically effective inhuman 
depression.
 
Procedure 
The procedures for Forced swim test or Despair swim test were similar to those first 
described by Porsolt.,et al. (1977). Male albino mice weighing 20-22 g are used. They are 
brought to the laboratory at least one day before the experiment and are housed separately in 
Makrolon® cages with free access to food and water. This test is sensitive to all major classes 
of antidepressant drugs, hence used as an animal model of depression like behaviour. Mice 
were grouped into three of five animals each and were trained individually for three 
consecutive days (pre-test session). In the “test-session” The animals were made to swim 
individually in an open cylindrical container of diameter 20cm and height 50cm, containing 
25cm of water at 25˚C, for a test period of 6 minutes. After a brief period of vigorous activity 
for about two minutes, mice maintain a typical immobile posture. The animals were 
considered immobile when they float in an upright position, making only negligible 
movements to maintain their head above water. The total duration of immobility was 
recorded and changes in the same were studied for various treatment groups. 
[75] 
Experimental Design:
 
 Swiss albino mice weighed around 20-25g were used for the study. Mice were divided 
into five groups of 5 animals each ,
 
Group-1 : Received normal saline (0.1% solution) 
Group-2 : Received standard drug, imipramine (60mg/kg.i.p) 
Group-3 : Received methanol extract of leaves of AV (250mg/kg; p.o. Low dose) 
Group-4 : Received methanol extract of leaves of AV (500mg/kg; p.o. High dose) 
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Tail suspension Test (TST) 
Principle 
The tail suspension test (TST) was developed as a rodent screening test for potential 
(human) antidepressants drugs. It is based on the assumption that an animal will actively try 
to escape an aversive (stressful) stimulus. If escape is impossible, the animal will eventually 
stop trying (“give up”). In the TST a mouse is suspended by the tail so that its body dangles 
in the air, facing downward. The test latest for ten minutes and may be repeated multiple 
times. Mice initially struggling and hangs immobile it is considered to have “given up”. 
Longer periods of immobility are characteristic of a depressive-like state. The validity of this 
test stems from the finding that treatment with an anti-depressants drug will decrease the time 
the animal spends immobile. 
Procedure 
The total duration of immobility induced by tail suspension was measured according 
to the method described by Steru et al (1985). Depression was produced by suspending the 
animal from the edge of a table 50 cm above the floor by an adhesive tape placed approx. 
1cm from the tip of the tail. Immobility time was recorded during a 6 min. period. Changes in 
the immobility duration were studied after administering drugs in separate groups of animals. 
The antidepressant activity was expressed as reduction in the immobility duration between 
the control, standard and animals treated with test drug.
 [76] 
Experimental Design 
 Swiss albino mice weighed around 20-25g were used for the study. Mice were divided 
into five groups of 5 animals each , 
Group-1 : Received normal saline (0.1% solution) 
Group-2 : Received standard drug, imipramine (60mg/kg.i.p) 
Group-3 : Received methanol extract of leaves of AV (250mg/kg; p.o. Low dose) 
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Group-4 : Received methanol extract of leaves of AV (500mg/kg; p.o. High dose) 
ANIMAL MODELS FOR ANTI-ANXIETY 
The animal model is considered one of most widely validated tests of assaying 
sedative and anxiolytic substances such as benzodiazepines. The test drug induced anxiolytic 
effect beginning at lower doses employed. An increase of most important variables of EPM 
test was found as follow; the percentage of time of mice spend on the open arms as well as 
the percentage of entries in the dark arms. The anxiolytic effect is also evidenced through 
light and dark test. As with the EPM test, this model is useful for modeling of anxiety. The 
low dose dependent effect could be attributed to biological variability, as well as chemical 
complexity of the test drug. Various model of anti anxiolytic testing are,  
Elevated Plus-Maze Test (EPM) 
 Principle 
Out of many possibilities to modify maze tests e.g. water maze, the Y‐mace, the radial 
maze, and the elevated plus maze have found acceptance in many laboratories. The test has 
been proposed for selective identification of anxiolytic and anxiogenic drugs. Anxiolytic 
compounds, by decreasing anxiety, increase the open arm exploration time; anxiogenic 
compounds have the opposite effect. 
Procedure 
 The plus maze for mice (Lister, 1987) consisted of two perpendicular open arms 
(30×5cm) and two closed arms (30×5×15cm) also in perpendicular position. The open and 
closed arms were connected with each other by a central platform (5×5cm). The lateral walls 
of the closed arm and floor of each arm were made of wood. The platform and lateral walls 
were painted in black. The maze was elevated at a height of 45cm above the floor. The 
animals were trained for two consecutive days (pre-test session). In the test-session, 30 
minutes after the treatment with standard and sample, the animal was placed at the center of 
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the maze with its nose facing in the direction of one of the closed arms. The duration of the 
test period was 10 minutes, during which the following parameters were evaluated. 
 The number of entries into the open arm. 
 The number of entries into the closed arm. 
 Time spent in the open arm. 
 Time spent in the closed arm. 
 The experiment was carried out in a sound attenuated room. An entry was counted 
when the animal placed all its four paws on an arm.
 [77] 
Experimental Design 
 Swiss albino mice weighed around 20-25g were used for the study. Mice were divided 
into five groups of 5 animals each , 
Group-1 : Received normal saline (0.1% solution) 
Group-2 : Received standard drug, diazepam (4mg/kg.i.p) 
Group-3 : Received methanol extract of leaves of AV (250mg/kg; p.o. Low dose) 
Group-4 : Received methanol extract of leaves of AV (500mg/kg; p.o. High dose) 
Light-Dark model 
Principle 
The light compartment is believed to be more aversive to the mouse than the dark 
compartment. Anxiolytic drug administration increases the number of entries to the light 
compartment; time spent in the light compartment and reduces freezing behaviour. 
Procedure 
The apparatus consists of a Plexiglas box with two compartments (20 x 20 cm) one of 
which is illuminated with a white light while the other remained dark. Each animal is placed 
at the centred of the illuminated compartments; facing one of the dark places, as well as the 
number of entries in each space is recorded for 3 min.
 [78]  
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Experimental Design 
 Swiss albino mice weighed around 20-25g were used for the study. Mice were divided 
into five groups of 5 animals each , 
Group-1 : Received normal saline (0.1%) 
Group-2 : Received standard drug, imipramine (60mg/kg.i.p) 
Group-3 : Received methanol extract of leaves of AV (250mg/kg; p.o. Low dose) 
Group-4 : Received methanol extract of leaves of AV (500mg/kg; p.o. High dose) 
Statistical Analysis 
 All the data were expressed as the mean ± standard error of the mean (SEM). The 
statistical significance of the difference between the groups was analyzed by using Graphpad 
5.0 software (Graphpad, San Diego, USA) by applying one was analysis of variance 
(ANOVA) followed by Dunnett‟s test as post hoc and also student‟s paired T-test. The value 
of P<0.05 was considered to be statistically significant. 
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7. RESULT AND DISCUSSION 
 
Table -4: Data showing colour, Consistency and yields of methanolic extract of powdered 
leaf of Amaranthus viridis Linn 
 
 
 
S.NO 
 
 
EXTRACT 
 
 
COLOUR 
 
 
CONSISTENCY 
 
 
 
%YIELD (W/W) 
 
 
1. 
 
 
Methanolic 
Extract 
 
 
Dark Green 
 
 
Sticky Mass 
 
 
12 % (w/w) 
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PHARMACOGNOSTICAL STUDIES 
Transverse section (T.S) of leaves of  Amaranthus viridis.L 
T.S of petiole of leaves A.viridis.L 
 
 
 
 
 
 
 
 
 
 
 
 
Fig: 9. T.S of petiole of leaves of Amaranthus viridis.L 
(Tr: Trichome, Ep: Epidermis, Pa: Parenchyma, Vb: Vascular bundle) 
Description 
Epidermis: 
The outer most layer of the petiole is epidermis. This is a single layer of parenchymal 
cells with anticlinal cell wall, almost circular, covered by cuticle. The stomata and trichomes 
are very rarely found. Tannins are found as a cell inclusion. 
Cortex: 
Cortex is made up of polygonal, collenchymatous parenchyma, compactly packed, no 
intercellular spaces, heavy in cellulose, thick walled.  
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Vascular bundle: 
Numerous vascular strands are seen in the middle portion of petiole. They are 
bicollatral covered by pericyclic fibre which made up of lignified sclerenchyma cells. Xylem 
appears as round cells with high lignin content. Phloem is non lignified surrounding the 
xylem. 
T.S of midrib leaves of Amaranthus viridis.L 
 
 
 
 
 
 
 
 
 
 
 
 
Fig- 10:  T.S of midrib of leaves of  Amaranthus viridis.L 
(Tr: Trichome, Ep: Epidermis, Pa: Parenchyma,  Co: Collenchyma, Xy: Xylem, Ph: Phloem, 
La: Lamina, Pl: Palidase) 
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The T.S of midrib shows the following characters: 
Epidermis:  
It is a single layer of quadrangular parenchymal cell with wavy anticlinal cell walls, 
covered by cuticle externally. The stomatal pores are seen occasionally. The trichomes are 
both covering and glandular type. 
Collenchyma: 
Two to three rows of thick walled, cellulosic collenchymas cells are present both 
upper and lower epidermis giving mechanical strength to the inner oragans. 
Parenchyma: 
Polygonal, thick walled, different sixed parenchymal cells are seen in the cortical 
layer often filled with tannins and starch. 
Vascular bundle: 
Vascular bundle is located exactly in the middle. Made up of four round vascular 
bundle consist of lignified xylem, non lignified phloem surrounded by lignified 
sclerenchymatous fibres.  
 
 
 
 
 
 
 
       RESULT AND DISCUSSION                                                          
DEPT.OF PHARMACOLOGY, THE ERODE COLLEGE OF PHARMACY & RESEARCH INSTITUTE93 
 
T.S of lamina of the leaves of Amaranthus viridis.L 
 
 
 
 
 
 
 
 
 
Fig -11:  T.S of the lamina of the leaf of Amaranthus viridis.L 
(Tr: Trichome, Ep: Epidermis, Pa: Palidase Parenchyma, Xy: Xylem, Ph: Phloem, Me: 
Mesophyll) 
Type of the leaf:  
Isobilateral. Both upper and lower epidermis are consists of same cellular 
arrangement. 
Upper epidermis:  
Single layer of quadrangular parenchyma cells, anitclinal walls, cuticularised, 
showing covering and glandular trichomes and stomatal pores occasionally. 
Palisade parenchyma: 
Palisade is a single layer of longitudinally elongated, compactly arranged 
parenchymal cells. Rich in chlorophyll pigments. They are not continuous in the midrib 
region. They are replaced by the presence of collenchymas cells in midrib region.  
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Mesophyll: 
Mesophyll is spongy in nature. In-betweens the palisade parenchyma, three to four 
rows of spongy parenchyma, thin walled, leaving large inter cellular spaces have been in the 
mesophyll region. The cells are consist cell inclusion as calcium oxalate crystals and starch 
grains. 
Lower palisade:  
Both upper and lower palisade layers are same. 
Lower epidermis:  
same as upper epidermis. The number of stomatal pores are more in lower epidermis. 
Trichomes:  
Covering trichomes: multicellular, uniseriate without branches, blunt at apex. 
Glandular trichomes: unicellular body and unicellular head. 
Venation pattern of leaves of Amaranthus viridis.L 
 
Fig -12 : venation pattern of leaves of Amaranthus viridis.L 
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Description: 
After clearing with clearing reagent, the leaf shows pinnate venation pattern. It shows 
the present of lateral veins, vein lets, vein islets and vein terminations. It also shows the 
presence of tannins and calcium salt deposition on the cell wall. 
ANALYTICAL PARAMETERS 
The analytical parameter were investigated and reported as total ash value (06.3% 
w/w), Water soluble ash value (1.20% w/w), Acid insoluble ash value (2.60%), Sulphated ash 
value (2.90% w/w), Water soluble extractive value (12.75% w/w), Alcohol soluble extractive 
value (12.60% w/w), Loss on drying (8.90% w/w). The above studies were enabled to 
identify the plant material for future investigation and form an important aspect of drug 
studies. 
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Table- 5:  The results were in the following table: Data for ash values for powdered 
leaves of Amaranthus viridis.L 
S.No 
PHYSICAL PARAMETERS 
(ASH VALUES) 
PERCENTAGE (W/W) 
1. Total ash value 06.8W% 
2. Water soluble ash 1.20% 
3. Acid soluble ash 2.60% 
4. Sulphated ash 2.90% 
 
EXTRACTIVE VALUE AND LOSS OF DRYING 
Table- 6: Data for extractive value and loss on drying of powdered leaf of Amaranthus 
viridis Linn 
S.NO ANALYTICAL PARAMETERS PERCENTAGE (W/W) 
1.  Alcohol soluble Extractive Value 12.6% 
2. Water soluble Extractive Value 12.75% 
3. Moisture content 8.90% 
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Table- 7:  Results of the phytochemical constituents of Methanolic Extract of Amaranthus 
viridis.L. 
S.No Constituents Methanolic extract of Leaves of 
Amaranthus viridis.L. 
1. CARBOHYDRATES + Ve 
2. FIXED OILS AND FATS -Ve 
3. PROTEIN AND AMINO ACID + Ve 
4. SAPONINS + Ve 
5. STEROIDS +Ve 
6. ALKALOIDS +Ve 
7. GLYCOSIDES +Ve 
8. FLAVONOIDS +Ve 
9. TANNINS +Ve 
10. GUM & MUCILAGE -Ve 
11. TRITERPENOIDS +Ve 
12. PHENOLIC COMPOUNDS +Ve 
 
(+)  Presence (-) Absence 
 
 
 
 
 
       RESULT AND DISCUSSION                                                          
DEPT.OF PHARMACOLOGY, THE ERODE COLLEGE OF PHARMACY & RESEARCH INSTITUTE98 
 
PHARMACOLOGICAL STUDIES 
EVALUATION OF NEUROPROTECTIVE EFFECT: 
ANTI-CONVULSANT ACTIVITY 
Table- 8: Effect of Methanolic extracts of Amaranthus viridis.L. on Maximal 
electroshock induced in rats 
Group 
Dose 
(mg/kg) 
Flexion Extension Clonus Stupor 
Recovery 
/ Death 
Control 
Normal 
saline 
15.35±0.157 13.5±0.025 14.13±0.035 6.09±0.039 Recovery 
Phenytoin 
20 
mg/kg 
3.14±0.049*** 0 3.17±0.036*** 1.07±0.023*** Recovery 
MEAV 
250 
mg/kg 
4.20±0.067*** 1.05±0.010*** 5.73±0.108*** 3.63±0.025*** Recovery 
MEAV 
500 
mg/kg 
3.29±0.049*** 0.72±0.014*** 4.53±0.028*** 1.10±0.026*** Recovery 
 
Note: Values were expressed as mean ± SEM. Statistical analysis was done by one way 
ANOVA followed by Dunnett‟s test as compared to the control group. 
***P<0.001; ns= non-significant; N = 5. 
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Fig- 8: Diagrammatic representation of Effects of Methanolic Extract of A.viridis on 
Maximal electroshock induce in rats 
Flexion
co
nt
ro
l
st
an
da
rd
lo
w
 d
os
e 
M
E
A
V
hi
gh
 d
os
e 
M
E
A
V
0
5
10
15
20
Groups
se
c
/m
in
 
 
Extension
co
nt
ro
l
st
an
da
rd
lo
w
 d
os
e 
M
E
A
V
hi
gh
 d
os
e 
M
E
A
V
0
5
10
15
Groups
se
c
/m
in
 
 
       RESULT AND DISCUSSION                                                          
DEPT.OF PHARMACOLOGY, THE ERODE COLLEGE OF PHARMACY & RESEARCH INSTITUTE100 
 
 
Clonus
co
nt
ro
l
st
an
da
rd
lo
w
 d
os
e 
M
E
A
V
hi
gh
 d
os
e 
M
E
A
V
0
5
10
15
Groups
se
c
/m
in
 
 
Stupor
co
nt
ro
l
st
an
da
rd
lo
w
 d
os
e 
M
E
A
V
hi
gh
 d
os
e 
M
E
A
V
0
2
4
6
8
Groups
se
c
/m
in
 
 
 
       RESULT AND DISCUSSION                                                          
DEPT.OF PHARMACOLOGY, THE ERODE COLLEGE OF PHARMACY & RESEARCH INSTITUTE101 
 
ANTI-DEPRESSANT ACTIVITY 
Forced Swimming Test (TST):  
Table- 9:  Effect of Methanolic Extracts of Amaranthus viridis.L. on forced swimming 
test in mice 
Group Dose  (mg/kg) 
Duration of immobility 
time  (sec) 
Control Normal saline 105.5±1.658 
Imipramine 60 mg/kg 76.25±1.377*** 
MEAV 250 mg/kg 92.25±1.887*** 
MEAV 500 mg/kg 81.5±0.866*** 
 
Note: Values were expressed as mean ± SEM. Statistical analysis was done by one way 
ANOVA followed by Dunnett‟s test as compared to the control group. 
***P<0.001; ns= non-significant; N = 5. 
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Fig: 9- Diagrammatic representation of Effects of Methanolic Extracts of Amaranthus 
viridis.L. on forced swimming test in mice 
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Tail Suspension Test (TST) 
Table- 10:  Effect of Methanolic Extracts of Amaranthus viridis.L. on Tail suspension 
test in mice 
Group Dose  (mg/kg) 
Duration of immobility 
time  (sec) 
Control Normal saline 178±3.24 
Imipramine 60 mg/kg 109.8±1.75*** 
MEAV 250 mg/kg 131.3±3.119*** 
MEAV 500 mg/kg 118.8±1.887*** 
 
Note: Values were expressed as mean ± SEM. Statistical analysis was done by one way 
ANOVA followed by Dunnett‟s test as compared to the control group. 
***P<0.001; ns= non-significant; N = 5. 
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Fig- 10:  Diagrammatic representation of Effects of Methanolic Extracts of Amaranthus 
viridis.L. on Tail suspension test in mice 
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ANTI-ANXIETY ACTIVITY 
Elevated Plus Maze Test 
Table -11: Effect of Methanolic Extract of Amaranthus viridis.L. on Elevated plus maze 
(EPM) test in mice  
Group Dose (mg/kg) 
Time spent in 
closed arm (sec) 
Time spent in 
open arm (sec) 
Control Normal saline 429.4±0.1586 100.4±0.1304 
Diazepam 4 mg/kg   331.4±0.0312 ns 260.4±0.1493*** 
MEAV 250 mg/kg     305.5±0.04131 ns 205.5±0.1602** 
MEAV 500 mg/kg   351.4±0.1035 ns 220.4±0.2121*** 
 
Note: Values were expressed as mean ± SEM. Statistical analysis was done by one way 
ANOVA followed by Dunnett‟s test as compared to the control group. 
***P<0.001; ns= non-significant; N = 5. 
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Fig- 11:  Diagrammatic representation of Effects of Methanolic Extracts of Amaranthus 
viridis.L. on Elevated plus maze (EPM) test in mice 
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Light- Dark Model: 
Table-12:  Effect of Methanolic Extract of Amaranthus viridis.L. on Light Dark Model 
in mice 
Group Dose  (mg/kg) 
Time spent in the light 
chamber (sec) 
Control Normal saline 64.25±1.702 
Imipramine 60 mg/kg 130.5±0.866*** 
MEAV 250 mg/kg 108.3±1.436*** 
MEAV 500 mg/kg 102±1.08*** 
 
Note: Values were expressed as mean ± SEM. Statistical analysis was done by one way 
ANOVA followed by Dunnett‟s test as compared to the control group. 
***P<0.001; ns= non-significant; N = 5. 
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Fig-12: Diagrammatic representation of Effects of Amranthus viridis.L. Methanolic 
Extracts of Amaranthus viridis.L. on Light – Dark model in mice 
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DISCUSSION 
 
 The methanolic extract of leaves of Amaranthus viridis linn was evaluated for its 
neuroprotective activity. Preliminary phytochemical analysis revealed the presence of 
alkaloids, carbohydrates, saponins, glycosides, protein and amino acids, phenolic compounds. 
The present investigation of the methanolic extract of leaf of Amaranthus viridis.L produced 
central inhibitory effect in mice and rats. Behavioural pharmacology field makes  the 
concepts that are derived from pharmacology and psychology to study behaviour in animal 
models. The discovery of new compounds which act on CNS process (either CNS depressant 
or CNS stimulant) will-provide clinical useful information for validation of animals. This will 
also new insight to researcher to understand the physio-pathological and neurochemical 
process involved in investigation of new compounds.
 [79]
 
Advance in modern science and technology have contributed to a massive 
advancement in the quality of human life. However, contemporary life stresses are 
accountable for the surge in frequency of diversity of neurologic and psychiatric disorders 
like anxiety, depression, psychosis, schizophrenia, Parkinsonism, Alzheimer‟s disease, 
epilepsy etc. The drugs which are currently used for the treatment of these disorders provide 
symptomatic relief rather than altering the course of the disease. The Adverse effect of the 
drugs ranges from exasperating to hindering or potentially incurable effects. Furthermore, the 
overall functions and eminence of life outcome of patients still remains pitiable after 
treatment. Thus, for the treatment of diseases, there is a critical need to search for less toxic 
and more effective drugs. In this context, an increasing number of herbal products have been 
introduced as an alternative for treating these neurologic and psychiatric disorders. Ayurveda 
in contrast to the modern western medicine considers detoxification as the prime part of 
treatment and believes in the fact that ailments continues cracking up again and again as far 
as the disease causing factors are accessible in the body. The herbal products owing to their 
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less toxicity and adverse effects when compared with allopathic treatment have gained 
widespread utility for treatment of neuropsychopharmacological diseases
 [80] [81] 
Thus plant extract and herbal medicines have stood the test of time for their 
wellbeing, effectiveness, adequacy and lesser side effects. The current study deals with the 
inquiry of the effects of Amaranathus viridis, and plant extract in different animal models in 
the area of neuropsychopharmacology. 
Currently available anticonvulsant drugs are able to efficiently control epileptic 
seizures in about 50% of the patients, another 25% may show improvement where as the 
remainder does not benefit significantly. Furthermore, undesirable side effects from the drugs 
used clinically often render treatment difficult so that a demand for new types of 
anticonvulsants exists. One of the approaches to search for new antiepileptic drugs is the 
investigation of naturally occurring compounds, which may belong to new structural classes. 
In most common forms of epileptic seizures, effective drugs appear to work either by 
promoting the inactivated state of voltage activated Na+ channels or enhance GABA 
mediated synaptic inhibition. 
The observation of present study indicates that methanolic extract of Amaranthus 
viridis.L (MEAV) possesses anticonvulsant activity in rat. GABA is the major inhibitory 
neurotransmitter in the brain while glutamic acid is an excitatory neurotransmitter in the 
brain. The inhibition of GABA neurotransmitter and the enhancement of the action of 
glutamic acid have been shown to be the underlying factors in epilepsy.
 [82] 
 The present study shows that the methanolic extract of leaf of Amaranthus viridis.L 
protected some of the animals against seizures induced by maximal electroshock. 
Antiepileptic drugs which inhibit voltage-dependent Na+ channels, such as phenytoin can 
prevent MES-induced tonic extension. 
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 In MES‐induced convulsion animals represents grandmal type of epilepsy. It has often 
been stated that antiepileptic drugs that block MES‐induced tonic extension phase act by 
blocking seizure spread. Moreover, MES‐induced tonic extension phase can be prevented 
either by drugs that inhibit voltage‐dependent Na+ channels, such as phenytoin, valproate, 
felbamate and lamotrigine or by drugs that block glutaminergic excitation mediated by the N-
methyl‐ D‐Aspartate (NMDA) receptor such as felbamate. The MEAV showed 
anticonvulsant activity against MES‐induced convulsion, it was abolished tonic extension 
phase due to it might be either inhibit voltage-dependent Na+ channels or act as a NMDA 
antagonists.
[83][84] 
In the result of present study, MEAV (250-500 mg/kg) produced significant 
antidepressant effect in FST & TST. These models of depression are widely used to screen 
new antidepressant drugs. The tests are quite sensitive and relatively specific to all major 
classes of antidepressant drugs including TCAs, SSRIs, MAOI, Atypical antidepressants. The 
forced swimming test is the most widely used tool for assessing antidepressant activity 
pre‐ clinically. The widespread use of this simple model is mainly due to its ability to detect 
a broad spectrum of antidepressant agents. It has been argued that TST (Tail Suspension 
Test) is less stressful than FST (Forced swim test) and has greater pharmacological 
sensitivity. The results obtained from TST are in concordance with the validated FST by 
Porsolt et al. Environmental factors and hereditary factors play a major role in producing 
deficient monoaminergic transmission in central nervous system thereby producing 
symptoms of depression.
 [85] 
The EPM is one of the most widely validated tests and is highly sensitive to the 
influence of both anxiolytic and anxiogenic drugs acting at the gamma amino-butyric acid 
type A (GABAA) - benzodiazepine complex. In EPM, normal mice will normally prefer to 
spend much of their allotted time in the closed arms. This preference appears to reflect an 
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aversion towards open arms that is generated by the fears of the open spaces. Drug like 
diazepam that increases open arm exploration are considered as anxiolytic and the reverse 
holds true for anxiogenics. In this study, we observed that the administration of different 
doses (250 and 500 mg/ kg body weight) of methanolic extract of Amaranthus viridis.L. 
induced an anxiolytic-like effect in mice, as it increased open arm entries and the time spent 
in the open arms of the EPM when compared to the control animals.
[86] 
The light –dark test were used to access the anxiolytics potentials of Amaranthus 
viridis.L. In the light-dark test (250-500mh/kg) dose showed the most prominent anxiolytic –
like properties by spending the highest time in the light chamber. This corroborate the 
suggestions that the time mice spent in the illuminated side of the light dark chamber is the 
most useful and consistent parameter of anxiety.  
From the present study, it can be concluded that Amaranthus viridis.L. (MEAV) 
shows significant psychotherapeutics effects as antidepressants and anxiolytics agent. This 
research work has eliminated the involvement of neurotoxicity in the use of Amaranthus 
viridis.L for pharmacotherapy in anxiety and depression. Detailed laboratory analysis is 
required for a definitive conclusion and isolation of major active secondary metabolites 
responsible for these therapeutic actions. So, a potent antidepressants and anxiolytics may 
emerge from Amaranthus viridis. Since the extract shows potent anxiolytic and depressant 
effects nearly at same dose range hence it could also be used in treatment of mixed anxiety 
and depression syndrome.
 [87] 
Results of the present investigation suggest that the extract of Amaranthus viridis.L. 
possesses neuropharmacological activity and provide the scientific basis for the use of the 
plant in traditional system of medicine in the treatment of nervous disorders.
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9. SUMMARY AND CONCLUSION 
The present study was undertaken to determine the effect of neuropharmacological 
effects of  leaves of methanolic extract of Amaranthus viridis.L 
The pharmacognostical studies made on the Amaranthus viridis.L determines the 
various parameters for pharmacognostical standards. The present investigation deals with the 
report on microscopically, transverse section of A.viridis leaves of (petiole, midrib, lamina, 
venation pattern) and different chemical parameters have been determined. These findings 
will be towards establishing pharmacognostic standards on identification, purity, quality, 
classification of the plant, which is gaining relevance in plant drug research. The powdered 
leaves like ash values, extractive values and loss of drying gave valuable information. This 
helped for correct identification of plant 
The preliminary phytochemical investigation showed the presence of carbohydrates, 
alkaloids, steroids and sterols, glycosides, saponins, tannins, flavonoids and phenolic 
compounds 
Our conclusion, investigation suggests that methanolic extract of powdered leaves of 
Amaranthus viridis.L. Which possess potent neuroprotective effects in rats & mice.  
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10. FUTURE PROSPECTIVES 
The current study reveals that methanolic extract of Amaranthus viridis.L.is having 
neuroprotective activity. So in future we can go for, 
1. A lead molecule having the neuroprotective activity can be isolated from the extract 
of plant Amaranthus viridis.L. 
2. A.viridis.L. is an interesting weed vegetable with a good nutritional value. 
3. It certainly deserves more attention to determine wider domestication possibilities and 
optimum cultivation practices. 
4. Its medicinal properties need further investigation as well. 
5. More research is needed into the nutritional aspects and utilization of the Amaranthus 
viridis.L. 
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